Bibliography: library/10665-340190
The reference for library/10665-340190 (who-iris) and any references extracted from it. library · All references.
Export these 179 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD
✍ + Add reference (standalone node)
179 shown
-
World Health Organization (2021). Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. World Health Organization.
10665-340190· catalogue · link · repository record · ISBN 9789240022232 (electronic version) · source:catalogue/records/10665-340190.dc.json· held:library/10665-340190
export: BibTeX · RIS · CSL-JSON · DC XML -
UNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.1.jsonUNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- UNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-010.1 - provenance: extracted
- read from
references/10665-340190.sec-010.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
United Nations General Assembly. Political declaration on HIV and AIDS: intensifying our efforts to eliminate HIV and AIDS. New York: United Nations; 2011 (https://www.unaids.org/en/aboutunaids/unitednationsdeclarationsandgoals/2011highlevelmeetingonaids, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.2.jsonUnited Nations General Assembly. Political declaration on HIV and AIDS: intensifying our efforts to eliminate HIV and AIDS. New York: United Nations; 2011 (https://www.unaids.org/en/aboutunaids/unitednationsdeclarationsandgoals/2011highlevelmeetingonaids, accessed 4 February 2021).
- Issued
- 2011
- Type
- document
- Accessed
- 4 February 2021
- As printed
- United Nations General Assembly. Political declaration on HIV and AIDS: intensifying our efforts to eliminate HIV and AIDS. New York: United Nations; 2011 (https://www.unaids.org/en/aboutunaids/unitednationsdeclarationsandgoals/2011highlevelmeetingonaids, accessed 4 February 2021).
Sources
- www.unaids.org/en/aboutunaids/unitednationsdeclarationsandgoals/2011highlevelmeetingonaids (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.2 - provenance: extracted
- read from
references/10665-340190.sec-010.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
On the Fast-Track to an AIDS-free generation. Geneva: UNAIDS; 2016 (https://www.unaids.org/sites/default/files/media_asset/GlobalPlan2016_en.pdf, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.3.jsonOn the Fast-Track to an AIDS-free generation. Geneva: UNAIDS; 2016 (https://www.unaids.org/sites/default/files/media_asset/GlobalPlan2016_en.pdf, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- On the Fast-Track to an AIDS-free generation. Geneva: UNAIDS; 2016 (https://www.unaids.org/sites/default/files/media_asset/GlobalPlan2016_en.pdf, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-010.3 - provenance: extracted
- read from
references/10665-340190.sec-010.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Consolidated guidelines on HIV prevention, diagnosis, treatment and care of key populations. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/guidelines/keypopulations/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.4.jsonConsolidated guidelines on HIV prevention, diagnosis, treatment and care of key populations. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/guidelines/keypopulations/en, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Consolidated guidelines on HIV prevention, diagnosis, treatment and care of key populations. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/guidelines/keypopulations/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/guidelines/keypopulations/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.4 - provenance: extracted
- read from
references/10665-340190.sec-010.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Women and HIV – a spotlight on adolescent girls and young women. Geneva. UNAIDS; 2019 (https://www.unaids.org/en/resources/documents/2019/women-and-hiv, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.5.jsonWomen and HIV – a spotlight on adolescent girls and young women. Geneva. UNAIDS; 2019 (https://www.unaids.org/en/resources/documents/2019/women-and-hiv, accessed 4 February 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Women and HIV – a spotlight on adolescent girls and young women. Geneva. UNAIDS; 2019 (https://www.unaids.org/en/resources/documents/2019/women-and-hiv, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-010.5 - provenance: extracted
- read from
references/10665-340190.sec-010.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.6.jsonConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/arv/arv-2016/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.6 - provenance: extracted
- read from
references/10665-340190.sec-010.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
HIV market report. Boston: Clinton Health Access Initiative; 2019 (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, accessed 1 March 2021).
· extracted · link · source:references/10665-340190.sec-010.7.jsonHIV market report. Boston: Clinton Health Access Initiative; 2019 (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, accessed 1 March 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 1 March 2021
- As printed
- HIV market report. Boston: Clinton Health Access Initiative; 2019 (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, accessed 1 March 2021).
Sources
- www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/ (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.7 - provenance: extracted
- read from
references/10665-340190.sec-010.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Making viral load routine: successes and failures in the implementation of routine HIV viral load monitoring. Geneva: Médecins Sans Frontières; 2016.
· extracted · source:references/10665-340190.sec-010.8.jsonMaking viral load routine: successes and failures in the implementation of routine HIV viral load monitoring. Geneva: Médecins Sans Frontières; 2016.
- Issued
- 2016
- Type
- document
- As printed
- Making viral load routine: successes and failures in the implementation of routine HIV viral load monitoring. Geneva: Médecins Sans Frontières; 2016.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-010.8 - provenance: extracted
- read from
references/10665-340190.sec-010.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.9.jsonHIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-010.9 - provenance: extracted
- read from
references/10665-340190.sec-010.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.10.jsonGlobal tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
Sources
- www.who.int/publications/i/item/9789240013131 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.10 - provenance: extracted
- read from
references/10665-340190.sec-010.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Global health sector strategy on HIV 2016–2021. Towards ending AIDS. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/strategy2016-2021/ghss-hiv/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.11.jsonGlobal health sector strategy on HIV 2016–2021. Towards ending AIDS. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/strategy2016-2021/ghss-hiv/en, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Global health sector strategy on HIV 2016–2021. Towards ending AIDS. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/strategy2016-2021/ghss-hiv/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/strategy2016-2021/ghss-hiv/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.11 - provenance: extracted
- read from
references/10665-340190.sec-010.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Department of Economic and Social Affairs. Sustainable Development Goals. New York: United Nations; 2015 (https://sdgs.un.org/goals, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-010.12.jsonDepartment of Economic and Social Affairs. Sustainable Development Goals. New York: United Nations; 2015 (https://sdgs.un.org/goals, accessed 4 February 2021).
- Issued
- 2015
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Department of Economic and Social Affairs. Sustainable Development Goals. New York: United Nations; 2015 (https://sdgs.un.org/goals, accessed 4 February 2021).
Sources
- sdgs.un.org/goals (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.12 - provenance: extracted
- read from
references/10665-340190.sec-010.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/145714, accessed 4 January 2021).
· extracted · link · source:references/10665-340190.sec-010.13.jsonWHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/145714, accessed 4 January 2021).
- Issued
- 2014
- Type
- document
- Accessed
- 4 January 2021
- As printed
- WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/145714, accessed 4 January 2021).
Sources
- apps.who.int/iris/handle/10665/145714 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-010.13 - provenance: extracted
- read from
references/10665-340190.sec-010.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
· extracted · source:references/10665-340190.sec-010.14.jsonGuyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
- Issued
- 2008
- Type
- article-journal
- As printed
- Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924–6.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-010.14 - provenance: extracted
- read from
references/10665-340190.sec-010.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-010-references.md
-
Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973.
· extracted · source:references/10665-340190.sec-014.1.jsonFonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973.
- Issued
- 2016
- Type
- article-journal
- As printed
- Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30:1973.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.1 - provenance: extracted
- read from
references/10665-340190.sec-014.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015 (https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.2.jsonGuideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015 (https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en, accessed 4 February 2021).
- Issued
- 2015
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization; 2015 (https://www.who.int/hiv/pub/guidelines/earlyrelease-arv/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.2 - provenance: extracted
- read from
references/10665-340190.sec-014.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
UNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.3.jsonUNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- UNAIDS data. Geneva: UNAIDS; 2020 (https://www.unaids.org/en/resources/documents/2020/unaids-data, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.3 - provenance: extracted
- read from
references/10665-340190.sec-014.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Dapivirine Vaginal Ring 25 mg (dapivirine): An overview of Dapivirine Vaginal Ring 25 mg and why it received a positive opinion. Amsterdam: European Medicines Agency 2020.
· extracted · source:references/10665-340190.sec-014.4.jsonDapivirine Vaginal Ring 25 mg (dapivirine): An overview of Dapivirine Vaginal Ring 25 mg and why it received a positive opinion. Amsterdam: European Medicines Agency 2020.
- Issued
- 2020
- Type
- document
- As printed
- Dapivirine Vaginal Ring 25 mg (dapivirine): An overview of Dapivirine Vaginal Ring 25 mg and why it received a positive opinion. Amsterdam: European Medicines Agency 2020.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.4 - provenance: extracted
- read from
references/10665-340190.sec-014.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Ahmed K, Baeten JM, Beksinska M, Bekker LG, Bukusi EA, Donnell D et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394:303–13.
· extracted · source:references/10665-340190.sec-014.5.jsonAhmed K, Baeten JM, Beksinska M, Bekker LG, Bukusi EA, Donnell D et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394:303–13.
- Issued
- 2019
- Type
- article-journal
- As printed
- Ahmed K, Baeten JM, Beksinska M, Bekker LG, Bukusi EA, Donnell D et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019;394:303–13.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.5 - provenance: extracted
- read from
references/10665-340190.sec-014.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Celum CL, Delany-Moretlwe S, Hosek S, Dye BJ, Bekker L-G, Mgodi N. Risk behavior, perception, and reasons for PrEP among young African women in HPTN 082. Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 4–7 March 2018 (https://www.croiconference.org/abstract/risk-behavior-perception-and-reasons-prep-among-young-african-women-hptn-082, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.6.jsonCelum CL, Delany-Moretlwe S, Hosek S, Dye BJ, Bekker L-G, Mgodi N. Risk behavior, perception, and reasons for PrEP among young African women in HPTN 082. Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 4–7 March 2018 (https://www.croiconference.org/abstract/risk-behavior-perception-and-reasons-prep-among-young-african-women-hptn-082, accessed 4 February 2021).
- Issued
- 2018
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Celum CL, Delany-Moretlwe S, Hosek S, Dye BJ, Bekker L-G, Mgodi N. Risk behavior, perception, and reasons for PrEP among young African women in HPTN 082. Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA, 4–7 March 2018 (https://www.croiconference.org/abstract/risk-behavior-perception-and-reasons-prep-among-young-african-women-hptn-082, accessed 4 February 2021).
Sources
- www.croiconference.org/abstract/risk-behavior-perception-and-reasons-prep-among-young-african-women-hptn-082 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.6 - provenance: extracted
- read from
references/10665-340190.sec-014.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Atukunda M et al. Lower than expected HIV incidence among men and women at elevated HIV risk in a population-based PrEP study in rural Kenya and Uganda: interim results from the SEARCH study. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020 (Abstract No. 875; https://aids2020.org/wp-content/uploads/2020/07/HIV-Highlights-Press-Conference-Abstracts.pdf, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.7.jsonKoss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Atukunda M et al. Lower than expected HIV incidence among men and women at elevated HIV risk in a population-based PrEP study in rural Kenya and Uganda: interim results from the SEARCH study. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020 (Abstract No. 875; https://aids2020.org/wp-content/uploads/2020/07/HIV-Highlights-Press-Conference-Abstracts.pdf, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Atukunda M et al. Lower than expected HIV incidence among men and women at elevated HIV risk in a population-based PrEP study in rural Kenya and Uganda: interim results from the SEARCH study. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020 (Abstract No. 875; https://aids2020.org/wp-content/uploads/2020/07/HIV-Highlights-Press-Conference-Abstracts.pdf, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.7 - provenance: extracted
- read from
references/10665-340190.sec-014.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21:e25094.
· extracted · source:references/10665-340190.sec-014.8.jsonvan der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21:e25094.
- Issued
- 2018
- Type
- article-journal
- As printed
- van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21:e25094.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.8 - provenance: extracted
- read from
references/10665-340190.sec-014.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN et al. End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22:e25283.
· extracted · source:references/10665-340190.sec-014.9.jsonMontgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN et al. End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22:e25283.
- Issued
- 2019
- Type
- article-journal
- As printed
- Montgomery ET, Beksinska M, Mgodi N, Schwartz J, Weinrib R, Browne EN et al. End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22:e25283.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.9 - provenance: extracted
- read from
references/10665-340190.sec-014.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Marrazzo JM, Del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH et al. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel. Jama. 2014 Jul 23;312(4):390-409.
· extracted · source:references/10665-340190.sec-014.10.jsonMarrazzo JM, Del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH et al. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel. Jama. 2014 Jul 23;312(4):390-409.
- Issued
- 2014
- Type
- document
- As printed
- Marrazzo JM, Del Rio C, Holtgrave DR, Cohen MS, Kalichman SC, Mayer KH et al. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel. Jama. 2014 Jul 23;312(4):390-409.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.10 - provenance: extracted
- read from
references/10665-340190.sec-014.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
WHO implementation tool for pre-exposure prophylaxis of HIV infection. Geneva, Switzerland: World Health Organization. 2017. (https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/, accessed 21 February 2021).
· extracted · link · source:references/10665-340190.sec-014.11.jsonWHO implementation tool for pre-exposure prophylaxis of HIV infection. Geneva, Switzerland: World Health Organization. 2017. (https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/, accessed 21 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 21 February 2021
- As printed
- WHO implementation tool for pre-exposure prophylaxis of HIV infection. Geneva, Switzerland: World Health Organization. 2017. (https://www.who.int/hiv/pub/prep/prep-implementation-tool/en/, accessed 21 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.11 - provenance: extracted
- read from
references/10665-340190.sec-014.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375:2133–43.
· extracted · source:references/10665-340190.sec-014.12.jsonNel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375:2133–43.
- Issued
- 2016
- Type
- article-journal
- As printed
- Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375:2133–43.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.12 - provenance: extracted
- read from
references/10665-340190.sec-014.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
· extracted · source:references/10665-340190.sec-014.13.jsonBaeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
- Issued
- 2016
- Type
- article-journal
- As printed
- Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.13 - provenance: extracted
- read from
references/10665-340190.sec-014.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e77-86.
· extracted · source:references/10665-340190.sec-014.14.jsonNel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e77-86.
- Issued
- 2021
- Type
- document
- As printed
- Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e77-86.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.14 - provenance: extracted
- read from
references/10665-340190.sec-014.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e87-95.
· extracted · source:references/10665-340190.sec-014.15.jsonBaeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e87-95.
- Issued
- 2021
- Type
- document
- As printed
- Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet HIV. 2021 Feb 1;8(2):e87-95.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.15 - provenance: extracted
- read from
references/10665-340190.sec-014.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Brown E, Hendrix C, van der Straten A, Kiweewa F, Mgodi N, Palanee‐Philips T et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial. J Int AIDS Soc. 2020;23:e25634.
· extracted · source:references/10665-340190.sec-014.16.jsonBrown E, Hendrix C, van der Straten A, Kiweewa F, Mgodi N, Palanee‐Philips T et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial. J Int AIDS Soc. 2020;23:e25634.
- Issued
- 2020
- Type
- article-journal
- As printed
- Brown E, Hendrix C, van der Straten A, Kiweewa F, Mgodi N, Palanee‐Philips T et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial. J Int AIDS Soc. 2020;23:e25634.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.16 - provenance: extracted
- read from
references/10665-340190.sec-014.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, Bekker L-G, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS ONE. 2016;11:e0147743.
· extracted · source:references/10665-340190.sec-014.17.jsonNel A, Bekker L-G, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS ONE. 2016;11:e0147743.
- Issued
- 2016
- Type
- article-journal
- As printed
- Nel A, Bekker L-G, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS ONE. 2016;11:e0147743.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.17 - provenance: extracted
- read from
references/10665-340190.sec-014.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
MTN-042 – a study of PrEP and the dapivirine ring in pregnant women 2020 (https://mtnstopshiv.org/research/studies/mtn-042, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.18.jsonMTN-042 – a study of PrEP and the dapivirine ring in pregnant women 2020 (https://mtnstopshiv.org/research/studies/mtn-042, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- MTN-042 – a study of PrEP and the dapivirine ring in pregnant women 2020 (https://mtnstopshiv.org/research/studies/mtn-042, accessed 4 February 2021).
Sources
- mtnstopshiv.org/research/studies/mtn-042 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.18 - provenance: extracted
- read from
references/10665-340190.sec-014.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
MTN-043 – B-PROTECTED: Breastfeeding PrEP & ring open-label trial 2020 (https://mtnstopshiv.org/news/studies/mtn043, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.19.jsonMTN-043 – B-PROTECTED: Breastfeeding PrEP & ring open-label trial 2020 (https://mtnstopshiv.org/news/studies/mtn043, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- MTN-043 – B-PROTECTED: Breastfeeding PrEP & ring open-label trial 2020 (https://mtnstopshiv.org/news/studies/mtn043, accessed 4 February 2021).
Sources
- mtnstopshiv.org/news/studies/mtn043 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.19 - provenance: extracted
- read from
references/10665-340190.sec-014.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Rosenberg Z, Nel A, van Niekerk N, Van Baelen B, Van Roey J, Palanee-Phillips T et al. Pooled efficacy analysis of two Phase III trials of dapivirine vaginal ring for the reduction of HIV-1 infection risk in HIV-uninfected women in sub-Saharan Africa. 9th IAS Conference on Health Science, Paris, France, 23–26 July 2017 (http://programme.ias2017.org/Abstract/Abstract/5704, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.20.jsonRosenberg Z, Nel A, van Niekerk N, Van Baelen B, Van Roey J, Palanee-Phillips T et al. Pooled efficacy analysis of two Phase III trials of dapivirine vaginal ring for the reduction of HIV-1 infection risk in HIV-uninfected women in sub-Saharan Africa. 9th IAS Conference on Health Science, Paris, France, 23–26 July 2017 (http://programme.ias2017.org/Abstract/Abstract/5704, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Rosenberg Z, Nel A, van Niekerk N, Van Baelen B, Van Roey J, Palanee-Phillips T et al. Pooled efficacy analysis of two Phase III trials of dapivirine vaginal ring for the reduction of HIV-1 infection risk in HIV-uninfected women in sub-Saharan Africa. 9th IAS Conference on Health Science, Paris, France, 23–26 July 2017 (http://programme.ias2017.org/Abstract/Abstract/5704, accessed 4 February 2021).
Sources
- programme.ias2017.org/Abstract/Abstract/5704 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.20 - provenance: extracted
- read from
references/10665-340190.sec-014.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
· extracted · source:references/10665-340190.sec-014.21.jsonBaeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
- Issued
- 2016
- Type
- article-journal
- As printed
- Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V et al. 2016;375:2121–32.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.21 - provenance: extracted
- read from
references/10665-340190.sec-014.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, Van Baelen BE, Mans W, Louw C, Gama C, Mabude Z et al. Dapivirine vaginal ring reduces the risk of HIV-1 infection among women in Africa. 9th South Africa AIDS Conference, Durban, South Africa, 11–14 June 2019.
· extracted · source:references/10665-340190.sec-014.22.jsonNel A, Van Baelen BE, Mans W, Louw C, Gama C, Mabude Z et al. Dapivirine vaginal ring reduces the risk of HIV-1 infection among women in Africa. 9th South Africa AIDS Conference, Durban, South Africa, 11–14 June 2019.
- Issued
- 2019
- Type
- document
- As printed
- Nel A, Van Baelen BE, Mans W, Louw C, Gama C, Mabude Z et al. Dapivirine vaginal ring reduces the risk of HIV-1 infection among women in Africa. 9th South Africa AIDS Conference, Durban, South Africa, 11–14 June 2019.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.22 - provenance: extracted
- read from
references/10665-340190.sec-014.22.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Fonner V, Dalglish S. Dapivirine intervaginal ring as pre-exposure prophylaxis to prevent HIV among women at substantial risk of infection: a systematic review and meta-analysis. Unpublished. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-014.23.jsonFonner V, Dalglish S. Dapivirine intervaginal ring as pre-exposure prophylaxis to prevent HIV among women at substantial risk of infection: a systematic review and meta-analysis. Unpublished. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Fonner V, Dalglish S. Dapivirine intervaginal ring as pre-exposure prophylaxis to prevent HIV among women at substantial risk of infection: a systematic review and meta-analysis. Unpublished. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.23 - provenance: extracted
- read from
references/10665-340190.sec-014.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S et al. Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a Phase III trial. J Acquir Immune Defic Syndr. 2018;79:580.
· extracted · source:references/10665-340190.sec-014.24.jsonPalanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S et al. Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a Phase III trial. J Acquir Immune Defic Syndr. 2018;79:580.
- Issued
- 2018
- Type
- article-journal
- As printed
- Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S et al. Impact of partner-related social harms on women's adherence to the dapivirine vaginal ring during a Phase III trial. J Acquir Immune Defic Syndr. 2018;79:580.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.24 - provenance: extracted
- read from
references/10665-340190.sec-014.24.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K et al. Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception. J Acquir Immune Defic Syndr. 2017:76:e47.
· extracted · source:references/10665-340190.sec-014.25.jsonBalkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K et al. Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception. J Acquir Immune Defic Syndr. 2017:76:e47.
- Issued
- 2017
- Type
- document
- As printed
- Balkus JE, Palanee-Phillips T, Reddy K, Siva S, Harkoo I, Nakabiito C, Kintu K et al. Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception. J Acquir Immune Defic Syndr. 2017:76:e47.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.25 - provenance: extracted
- read from
references/10665-340190.sec-014.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
· extracted · source:references/10665-340190.sec-014.26.jsonMakanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
- Issued
- 2018
- Type
- article-journal
- As printed
- Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.26 - provenance: extracted
- read from
references/10665-340190.sec-014.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Kusemererwa S, Abaasa A, editors. Pregnancy incidence and outcomes among women using dapivirine vaginal ring for HIV prevention in a Phase III clinical trial in south western Uganda. AIDS Res Hum Retrovir. 2018;34:209.
· extracted · source:references/10665-340190.sec-014.27.jsonKusemererwa S, Abaasa A, editors. Pregnancy incidence and outcomes among women using dapivirine vaginal ring for HIV prevention in a Phase III clinical trial in south western Uganda. AIDS Res Hum Retrovir. 2018;34:209.
- Issued
- 2018
- Type
- article-journal
- As printed
- Kusemererwa S, Abaasa A, editors. Pregnancy incidence and outcomes among women using dapivirine vaginal ring for HIV prevention in a Phase III clinical trial in south western Uganda. AIDS Res Hum Retrovir. 2018;34:209.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.27 - provenance: extracted
- read from
references/10665-340190.sec-014.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Kusemererwa S, Abaasa A, editors. Does the use of the dapivirine vaginal ring result in change in risky sexual behavior? AIDS Res Hum Retrovir. 2018;34:209
· extracted · source:references/10665-340190.sec-014.28.jsonKusemererwa S, Abaasa A, editors. Does the use of the dapivirine vaginal ring result in change in risky sexual behavior? AIDS Res Hum Retrovir. 2018;34:209
- Issued
- 2018
- Type
- article-journal
- As printed
- Kusemererwa S, Abaasa A, editors. Does the use of the dapivirine vaginal ring result in change in risky sexual behavior? AIDS Res Hum Retrovir. 2018;34:209
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.28 - provenance: extracted
- read from
references/10665-340190.sec-014.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW et al. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost– effectiveness. J Int AIDS Soc. 2019;22:e25282.
· extracted · source:references/10665-340190.sec-014.29.jsonGlaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW et al. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost– effectiveness. J Int AIDS Soc. 2019;22:e25282.
- Issued
- 2019
- Type
- article-journal
- As printed
- Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW et al. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost– effectiveness. J Int AIDS Soc. 2019;22:e25282.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.29 - provenance: extracted
- read from
references/10665-340190.sec-014.29.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Glaubius R, Hood G, Parikh UM, Abbas U. Dapivirine vaginal ring preexposure prophylaxis for HIV prevention in South Africa. Topics Antivir Med. 2016;24:458.
· extracted · source:references/10665-340190.sec-014.30.jsonGlaubius R, Hood G, Parikh UM, Abbas U. Dapivirine vaginal ring preexposure prophylaxis for HIV prevention in South Africa. Topics Antivir Med. 2016;24:458.
- Issued
- 2016
- Type
- article-journal
- As printed
- Glaubius R, Hood G, Parikh UM, Abbas U. Dapivirine vaginal ring preexposure prophylaxis for HIV prevention in South Africa. Topics Antivir Med. 2016;24:458.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.30 - provenance: extracted
- read from
references/10665-340190.sec-014.30.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Smith J, Garnett G, Van Damme L, Hallett T. Cost–effectiveness of the intravaginal dapivirine ring: a modeling analysis. 23rd Conference on Retroviruses and Opportunistic Infections, 22–25 February 2016 (https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01250294/full, accessed 4 February 2021).
· extracted · doi:10.1002/central/CN-01250294/full · source:references/10665-340190.sec-014.31.jsonSmith J, Garnett G, Van Damme L, Hallett T. Cost–effectiveness of the intravaginal dapivirine ring: a modeling analysis. 23rd Conference on Retroviruses and Opportunistic Infections, 22–25 February 2016 (https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01250294/full, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- DOI
- 10.1002/central/CN-01250294/full
- Accessed
- 4 February 2021
- As printed
- Smith J, Garnett G, Van Damme L, Hallett T. Cost–effectiveness of the intravaginal dapivirine ring: a modeling analysis. 23rd Conference on Retroviruses and Opportunistic Infections, 22–25 February 2016 (https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01250294/full, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.31 - provenance: extracted
- read from
references/10665-340190.sec-014.31.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Reidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. PLoS One. 2019;14:e0218710.
· extracted · source:references/10665-340190.sec-014.32.jsonReidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. PLoS One. 2019;14:e0218710.
- Issued
- 2019
- Type
- article-journal
- As printed
- Reidy M, Gardiner E, Pretorius C, Glaubius R, Torjesen K, Kripke K. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. PLoS One. 2019;14:e0218710.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.32 - provenance: extracted
- read from
references/10665-340190.sec-014.32.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Kripke K, Reidy M, Bhavaraju N, Torjesen K, Gardiner E. Modeling the potential impact of the dapivirine ring for HIV prevention. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018 (https://www.prepwatch.org/wp-content/uploads/2018/08/OPTIONS_DapRingModeling_AIDS2018poster-1.pdf, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.33.jsonKripke K, Reidy M, Bhavaraju N, Torjesen K, Gardiner E. Modeling the potential impact of the dapivirine ring for HIV prevention. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018 (https://www.prepwatch.org/wp-content/uploads/2018/08/OPTIONS_DapRingModeling_AIDS2018poster-1.pdf, accessed 4 February 2021).
- Issued
- 2018
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Kripke K, Reidy M, Bhavaraju N, Torjesen K, Gardiner E. Modeling the potential impact of the dapivirine ring for HIV prevention. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018 (https://www.prepwatch.org/wp-content/uploads/2018/08/OPTIONS_DapRingModeling_AIDS2018poster-1.pdf, accessed 4 February 2021).
Sources
- www.prepwatch.org/wp-content/uploads/2018/08/OPTIONS_DapRingModeling_AIDS2018poster-1.pdf (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.33 - provenance: extracted
- read from
references/10665-340190.sec-014.33.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 2014;28:1479–87.
· extracted · source:references/10665-340190.sec-014.34.jsonNel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 2014;28:1479–87.
- Issued
- 2014
- Type
- article-journal
- As printed
- Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 2014;28:1479–87.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.34 - provenance: extracted
- read from
references/10665-340190.sec-014.34.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA et al. Phase 2a safety, pharmacokinetics, and acceptability of dapivirine vaginal rings in US postmenopausal women. Clin Infect Dis. 2019;68:1144–51.
· extracted · source:references/10665-340190.sec-014.35.jsonChen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA et al. Phase 2a safety, pharmacokinetics, and acceptability of dapivirine vaginal rings in US postmenopausal women. Clin Infect Dis. 2019;68:1144–51.
- Issued
- 2019
- Type
- article-journal
- As printed
- Chen BA, Zhang J, Gundacker HM, Hendrix CW, Hoesley CJ, Salata RA et al. Phase 2a safety, pharmacokinetics, and acceptability of dapivirine vaginal rings in US postmenopausal women. Clin Infect Dis. 2019;68:1144–51.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.35 - provenance: extracted
- read from
references/10665-340190.sec-014.35.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Bunge KE, Levy L, Szydlo DW, Zhang J, Gaur AH, Reirden D et al. Brief report: Phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women. J Acquir Immune Defic Syndr. 2020;83:135–9.
· extracted · source:references/10665-340190.sec-014.36.jsonBunge KE, Levy L, Szydlo DW, Zhang J, Gaur AH, Reirden D et al. Brief report: Phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women. J Acquir Immune Defic Syndr. 2020;83:135–9.
- Issued
- 2020
- Type
- article-journal
- As printed
- Bunge KE, Levy L, Szydlo DW, Zhang J, Gaur AH, Reirden D et al. Brief report: Phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women. J Acquir Immune Defic Syndr. 2020;83:135–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.36 - provenance: extracted
- read from
references/10665-340190.sec-014.36.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J et al. Vaginal ring acceptability and related preferences among women in low-and middle-income countries: a systematic review and narrative synthesis. PLoS One. 2019;14:e0224898.
· extracted · source:references/10665-340190.sec-014.37.jsonGriffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J et al. Vaginal ring acceptability and related preferences among women in low-and middle-income countries: a systematic review and narrative synthesis. PLoS One. 2019;14:e0224898.
- Issued
- 2019
- Type
- article-journal
- As printed
- Griffin JB, Ridgeway K, Montgomery E, Torjesen K, Clark R, Peterson J et al. Vaginal ring acceptability and related preferences among women in low-and middle-income countries: a systematic review and narrative synthesis. PLoS One. 2019;14:e0224898.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.37 - provenance: extracted
- read from
references/10665-340190.sec-014.37.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Schwartz K, Bhavaraju N, Ridgeway K, Gomez A. End-user perspectives on their ability, motivation and opportunity to use the dapivirine vaginal ring. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020.
· extracted · source:references/10665-340190.sec-014.38.jsonSchwartz K, Bhavaraju N, Ridgeway K, Gomez A. End-user perspectives on their ability, motivation and opportunity to use the dapivirine vaginal ring. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020.
- Issued
- 2020
- Type
- document
- As printed
- Schwartz K, Bhavaraju N, Ridgeway K, Gomez A. End-user perspectives on their ability, motivation and opportunity to use the dapivirine vaginal ring. 23rd International AIDS Conference, San Francisco, CA, USA, 6–10 July 2020.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.38 - provenance: extracted
- read from
references/10665-340190.sec-014.38.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Ridgeway KM, Smith K, Torjesen K, van der Straten A, Achilles SL. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Submitted.
· extracted · source:references/10665-340190.sec-014.39.jsonRidgeway KM, Smith K, Torjesen K, van der Straten A, Achilles SL. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Submitted.
- Type
- document
- As printed
- Ridgeway KM, Smith K, Torjesen K, van der Straten A, Achilles SL. Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Submitted.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.39 - provenance: extracted
- read from
references/10665-340190.sec-014.39.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nel A, Bekker LG, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS One. 2016;11:e0147743.
· extracted · source:references/10665-340190.sec-014.40.jsonNel A, Bekker LG, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS One. 2016;11:e0147743.
- Issued
- 2016
- Type
- article-journal
- As printed
- Nel A, Bekker LG, Bukusi E, Hellström E, Kotze P, Louw C et al. Safety, acceptability and countries in sub-Saharan Africa. PLoS One. 2016;11:e0147743.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.40 - provenance: extracted
- read from
references/10665-340190.sec-014.40.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
van der Straten A, Laborde N, Hoesley CJ, Cheng H, Husnik MJ. Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a Phase I study in the United States. AIDS Behav. 2016;20:2644–2653.
· extracted · source:references/10665-340190.sec-014.41.jsonvan der Straten A, Laborde N, Hoesley CJ, Cheng H, Husnik MJ. Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a Phase I study in the United States. AIDS Behav. 2016;20:2644–2653.
- Issued
- 2016
- Type
- article-journal
- As printed
- van der Straten A, Laborde N, Hoesley CJ, Cheng H, Husnik MJ. Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a Phase I study in the United States. AIDS Behav. 2016;20:2644–2653.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.41 - provenance: extracted
- read from
references/10665-340190.sec-014.41.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159.
· extracted · source:references/10665-340190.sec-014.42.jsonMontgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159.
- Issued
- 2017
- Type
- article-journal
- As printed
- Montgomery ET, van der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31:1159.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.42 - provenance: extracted
- read from
references/10665-340190.sec-014.42.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Culture Health Sexuality. 2019;21:1209–24.
· extracted · source:references/10665-340190.sec-014.43.jsonChitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Culture Health Sexuality. 2019;21:1209–24.
- Issued
- 2019
- Type
- article-journal
- As printed
- Chitukuta M, Duby Z, Katz A, Nakyanzi T, Reddy K, Palanee-Phillips T et al. Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Culture Health Sexuality. 2019;21:1209–24.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.43 - provenance: extracted
- read from
references/10665-340190.sec-014.43.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Duby Z, Katz AW, Browne EN, Mutero P, Etima J, Zimba CC et al. Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020;24:617–28.
· extracted · source:references/10665-340190.sec-014.44.jsonDuby Z, Katz AW, Browne EN, Mutero P, Etima J, Zimba CC et al. Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020;24:617–28.
- Issued
- 2020
- Type
- article-journal
- As printed
- Duby Z, Katz AW, Browne EN, Mutero P, Etima J, Zimba CC et al. Hygiene, blood flow, and vaginal overload: why women removed an HIV prevention vaginal ring during menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020;24:617–28.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.44 - provenance: extracted
- read from
references/10665-340190.sec-014.44.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M et al. Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex. AIDS Behav. 2018;22:437–46.
· extracted · source:references/10665-340190.sec-014.45.jsonLaborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M et al. Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex. AIDS Behav. 2018;22:437–46.
- Issued
- 2018
- Type
- article-journal
- As printed
- Laborde ND, Pleasants E, Reddy K, Atujuna M, Nakyanzi T, Chitukuta M et al. Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex. AIDS Behav. 2018;22:437–46.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.45 - provenance: extracted
- read from
references/10665-340190.sec-014.45.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Nair G, Roberts S, Baeten J, Palanee-Philips T, Katie S, Reddy K et al. Disclosure of vaginal ring use to male partners in an HIV prevention study: impact on adherence. AIDS Res Hum Retrovir. 2018;34:209.
· extracted · source:references/10665-340190.sec-014.46.jsonNair G, Roberts S, Baeten J, Palanee-Philips T, Katie S, Reddy K et al. Disclosure of vaginal ring use to male partners in an HIV prevention study: impact on adherence. AIDS Res Hum Retrovir. 2018;34:209.
- Issued
- 2018
- Type
- article-journal
- As printed
- Nair G, Roberts S, Baeten J, Palanee-Philips T, Katie S, Reddy K et al. Disclosure of vaginal ring use to male partners in an HIV prevention study: impact on adherence. AIDS Res Hum Retrovir. 2018;34:209.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.46 - provenance: extracted
- read from
references/10665-340190.sec-014.46.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81:304–10.
· extracted · source:references/10665-340190.sec-014.47.jsonvan der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81:304–10.
- Issued
- 2019
- Type
- article-journal
- As printed
- van der Straten A, Browne EN, Shapley-Quinn MK, Brown ER, Reddy K et al. First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring. J Acquir Immune Defic Syndr. 2019;81:304–10.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.47 - provenance: extracted
- read from
references/10665-340190.sec-014.47.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Ross J, Stover J. Use of modern contraception increases when more methods become available: analysis of evidence from 1982–2009. Global Health: Science and Practice. 2013 Aug 1;1(2):203-12.
· extracted · source:references/10665-340190.sec-014.48.jsonRoss J, Stover J. Use of modern contraception increases when more methods become available: analysis of evidence from 1982–2009. Global Health: Science and Practice. 2013 Aug 1;1(2):203-12.
- Issued
- 2013
- Type
- document
- As printed
- Ross J, Stover J. Use of modern contraception increases when more methods become available: analysis of evidence from 1982–2009. Global Health: Science and Practice. 2013 Aug 1;1(2):203-12.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.48 - provenance: extracted
- read from
references/10665-340190.sec-014.48.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Consolidated guidelines on HIV testing services. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/guidelines/hiv-testing-services/en/, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.49.jsonConsolidated guidelines on HIV testing services. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/guidelines/hiv-testing-services/en/, accessed 4 February 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Consolidated guidelines on HIV testing services. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/guidelines/hiv-testing-services/en/, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-014.49 - provenance: extracted
- read from
references/10665-340190.sec-014.49.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566.
· extracted · source:references/10665-340190.sec-014.50.jsonMakanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566.
- Issued
- 2018
- Type
- article-journal
- As printed
- Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y et al. Pregnancy J Acquir Immune Defic Syndr. 2018;79:566.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-014.50 - provenance: extracted
- read from
references/10665-340190.sec-014.50.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
NCT03074786: MTN-034/REACH (Reversing the Epidemic in Africa with Choices in HIV Prevention) 2020 (https://clinicaltrials.gov/ct2/show/NCT03074786, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-014.51.jsonNCT03074786: MTN-034/REACH (Reversing the Epidemic in Africa with Choices in HIV Prevention) 2020 (https://clinicaltrials.gov/ct2/show/NCT03074786, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- NCT03074786: MTN-034/REACH (Reversing the Epidemic in Africa with Choices in HIV Prevention) 2020 (https://clinicaltrials.gov/ct2/show/NCT03074786, accessed 4 February 2021).
Sources
- clinicaltrials.gov/ct2/show/NCT03074786 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-014.51 - provenance: extracted
- read from
references/10665-340190.sec-014.51.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-014-references.md
-
AIDSInfo [online database]. Geneva: UNAIDS; 2020 (http://aidsinfo.unaids.org, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.1.jsonAIDSInfo [online database]. Geneva: UNAIDS; 2020 (http://aidsinfo.unaids.org, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- AIDSInfo [online database]. Geneva: UNAIDS; 2020 (http://aidsinfo.unaids.org, accessed 4 February 2021).
Sources
- aidsinfo.unaids.org (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-021.1 - provenance: extracted
- read from
references/10665-340190.sec-021.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Bourne DE, Thompson M, Brody LL, Cotton M, Draper B, Laubscher R et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101–6.
· extracted · source:references/10665-340190.sec-021.2.jsonBourne DE, Thompson M, Brody LL, Cotton M, Draper B, Laubscher R et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101–6.
- Issued
- 2009
- Type
- article-journal
- As printed
- Bourne DE, Thompson M, Brody LL, Cotton M, Draper B, Laubscher R et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101–6.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.2 - provenance: extracted
- read from
references/10665-340190.sec-021.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.
· extracted · source:references/10665-340190.sec-021.3.jsonViolari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.
- Issued
- 2008
- Type
- article-journal
- As printed
- Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.3 - provenance: extracted
- read from
references/10665-340190.sec-021.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Markby J, Boeke C, Sacks J, Wang M, Peter T, Vojnov L. HIV early infant diagnosis testing programs in low- and middle-income countries: a systematic review and meta-analysis. In preparation.
· extracted · source:references/10665-340190.sec-021.4.jsonMarkby J, Boeke C, Sacks J, Wang M, Peter T, Vojnov L. HIV early infant diagnosis testing programs in low- and middle-income countries: a systematic review and meta-analysis. In preparation.
- Type
- document
- As printed
- Markby J, Boeke C, Sacks J, Wang M, Peter T, Vojnov L. HIV early infant diagnosis testing programs in low- and middle-income countries: a systematic review and meta-analysis. In preparation.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.4 - provenance: extracted
- read from
references/10665-340190.sec-021.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
WHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.5.jsonWHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- WHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.5 - provenance: extracted
- read from
references/10665-340190.sec-021.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.6.jsonConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/arv/arv-2016/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-021.6 - provenance: extracted
- read from
references/10665-340190.sec-021.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Luo R, Boeras D, Vojnov L. Systematic review on the clinical impact of point-of-care early infant diagnosis for HIV. In preparation. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-021.7.jsonLuo R, Boeras D, Vojnov L. Systematic review on the clinical impact of point-of-care early infant diagnosis for HIV. In preparation. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Luo R, Boeras D, Vojnov L. Systematic review on the clinical impact of point-of-care early infant diagnosis for HIV. In preparation. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.7 - provenance: extracted
- read from
references/10665-340190.sec-021.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Bianchi F, Cohn J, Sacks E, Bailey R, Lemaire JF, Machekano R et al. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries. Lancet HIV. 2019;6:e373–81.
· extracted · source:references/10665-340190.sec-021.8.jsonBianchi F, Cohn J, Sacks E, Bailey R, Lemaire JF, Machekano R et al. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries. Lancet HIV. 2019;6:e373–81.
- Issued
- 2019
- Type
- article-journal
- As printed
- Bianchi F, Cohn J, Sacks E, Bailey R, Lemaire JF, Machekano R et al. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries. Lancet HIV. 2019;6:e373–81.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.8 - provenance: extracted
- read from
references/10665-340190.sec-021.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Boeke C, Wang M, Abate Z. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programs across six African countries. Unpublished.
· extracted · source:references/10665-340190.sec-021.9.jsonBoeke C, Wang M, Abate Z. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programs across six African countries. Unpublished.
- Type
- document
- As printed
- Boeke C, Wang M, Abate Z. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programs across six African countries. Unpublished.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.9 - provenance: extracted
- read from
references/10665-340190.sec-021.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Jani IV, Meggi B, Loquiha O, Tobaiwa O, Mudenyanga C, Zitha A et al. Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients. AIDS. 2018;32:1453–63.
· extracted · source:references/10665-340190.sec-021.10.jsonJani IV, Meggi B, Loquiha O, Tobaiwa O, Mudenyanga C, Zitha A et al. Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients. AIDS. 2018;32:1453–63.
- Issued
- 2018
- Type
- article-journal
- As printed
- Jani IV, Meggi B, Loquiha O, Tobaiwa O, Mudenyanga C, Zitha A et al. Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients. AIDS. 2018;32:1453–63.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.10 - provenance: extracted
- read from
references/10665-340190.sec-021.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Chibwesha CJ, Mollan KR, Ford CE, Shibemba A, Saha PT, Lusaka M et al. A randomised trial of point-of-care early infant HIV diagnosis. (https://ssrn.com/abstract=3646123, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.11.jsonChibwesha CJ, Mollan KR, Ford CE, Shibemba A, Saha PT, Lusaka M et al. A randomised trial of point-of-care early infant HIV diagnosis. (https://ssrn.com/abstract=3646123, accessed 4 February 2021).
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Chibwesha CJ, Mollan KR, Ford CE, Shibemba A, Saha PT, Lusaka M et al. A randomised trial of point-of-care early infant HIV diagnosis. (https://ssrn.com/abstract=3646123, accessed 4 February 2021).
Sources
- ssrn.com/abstract=3646123 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-021.11 - provenance: extracted
- read from
references/10665-340190.sec-021.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Mwenda R, Fong Y, Magombo T, Saka E, Midiani D, Mwase C, Kandulu J et al. Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi. Clin Infect Dis. 2018;67:701–7.
· extracted · source:references/10665-340190.sec-021.12.jsonMwenda R, Fong Y, Magombo T, Saka E, Midiani D, Mwase C, Kandulu J et al. Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi. Clin Infect Dis. 2018;67:701–7.
- Issued
- 2018
- Type
- article-journal
- As printed
- Mwenda R, Fong Y, Magombo T, Saka E, Midiani D, Mwase C, Kandulu J et al. Significant patient impact observed upon implementation of point-of-care early infant diagnosis technologies in an observational study in Malawi. Clin Infect Dis. 2018;67:701–7.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.12 - provenance: extracted
- read from
references/10665-340190.sec-021.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Spooner E, Govender K, Reddy T, Ramjee G, Mbadi N, Singh S et al. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health. 2019;19:1–14.
· extracted · source:references/10665-340190.sec-021.13.jsonSpooner E, Govender K, Reddy T, Ramjee G, Mbadi N, Singh S et al. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health. 2019;19:1–14.
- Issued
- 2019
- Type
- article-journal
- As printed
- Spooner E, Govender K, Reddy T, Ramjee G, Mbadi N, Singh S et al. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study. BMC Public Health. 2019;19:1–14.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.13 - provenance: extracted
- read from
references/10665-340190.sec-021.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Technau K-G, Kuhn L, Coovadia A, Murnane PM, Sherman G. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017;4:e442–8.
· extracted · source:references/10665-340190.sec-021.14.jsonTechnau K-G, Kuhn L, Coovadia A, Murnane PM, Sherman G. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017;4:e442–8.
- Issued
- 2017
- Type
- article-journal
- As printed
- Technau K-G, Kuhn L, Coovadia A, Murnane PM, Sherman G. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017;4:e442–8.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.14 - provenance: extracted
- read from
references/10665-340190.sec-021.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Le Roux S, Myer L, Vojnov L. Cost–effectiveness of point-of-care nucleic acid testing for early infant diagnosis of HIV compared to centralized, laboratory-based testing: a systematic review of mathematical modelling studies. In preparation. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-021.15.jsonLe Roux S, Myer L, Vojnov L. Cost–effectiveness of point-of-care nucleic acid testing for early infant diagnosis of HIV compared to centralized, laboratory-based testing: a systematic review of mathematical modelling studies. In preparation. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Le Roux S, Myer L, Vojnov L. Cost–effectiveness of point-of-care nucleic acid testing for early infant diagnosis of HIV compared to centralized, laboratory-based testing: a systematic review of mathematical modelling studies. In preparation. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.15 - provenance: extracted
- read from
references/10665-340190.sec-021.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Salvatore PP, de Broucker G, Vojnov L, Moss WJ, Dowdy DW, Sutcliffe CG. Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries. AIDS. 2021 Feb 2;35(2):287-97.
· extracted · source:references/10665-340190.sec-021.16.jsonSalvatore PP, de Broucker G, Vojnov L, Moss WJ, Dowdy DW, Sutcliffe CG. Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries. AIDS. 2021 Feb 2;35(2):287-97.
- Issued
- 2021
- Type
- document
- As printed
- Salvatore PP, de Broucker G, Vojnov L, Moss WJ, Dowdy DW, Sutcliffe CG. Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries. AIDS. 2021 Feb 2;35(2):287-97.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.16 - provenance: extracted
- read from
references/10665-340190.sec-021.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
De Broucker G, Salvatore PP, Mutembo S, et al. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia. Unpublished.
· extracted · source:references/10665-340190.sec-021.17.jsonDe Broucker G, Salvatore PP, Mutembo S, et al. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia. Unpublished.
- Type
- document
- As printed
- De Broucker G, Salvatore PP, Mutembo S, et al. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia. Unpublished.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.17 - provenance: extracted
- read from
references/10665-340190.sec-021.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Frank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S et al. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019;6:e182–90.
· extracted · source:references/10665-340190.sec-021.18.jsonFrank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S et al. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019;6:e182–90.
- Issued
- 2019
- Type
- article-journal
- As printed
- Frank SC, Cohn J, Dunning L, Sacks E, Walensky RP, Mukherjee S et al. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study. Lancet HIV. 2019;6:e182–90.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.18 - provenance: extracted
- read from
references/10665-340190.sec-021.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
McCann NC, Cohn J, Flanagan C, Sacks E, Mukherjee S, Walensky RP et al. Strengthening existing laboratory-based systems vs. investing in point-of-care assays for early infant diagnosis of HIV: a model-based cost–effectiveness analysis. J Acquir Immune Defic Syndr. 2020;84(Suppl. 1):S12–21.
· extracted · source:references/10665-340190.sec-021.19.jsonMcCann NC, Cohn J, Flanagan C, Sacks E, Mukherjee S, Walensky RP et al. Strengthening existing laboratory-based systems vs. investing in point-of-care assays for early infant diagnosis of HIV: a model-based cost–effectiveness analysis. J Acquir Immune Defic Syndr. 2020;84(Suppl. 1):S12–21.
- Issued
- 2020
- Type
- document
- As printed
- McCann NC, Cohn J, Flanagan C, Sacks E, Mukherjee S, Walensky RP et al. Strengthening existing laboratory-based systems vs. investing in point-of-care assays for early infant diagnosis of HIV: a model-based cost–effectiveness analysis. J Acquir Immune Defic Syndr. 2020;84(Suppl. 1):S12–21.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.19 - provenance: extracted
- read from
references/10665-340190.sec-021.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Katirayi L, Ochuka B, Mafaune H, Chadambuka A, Baffour T, Sacks E. “We need it the same day”: a qualitative study of caregivers and community members’ perspectives toward the use of point-of-care early infant diagnosis. J Acquir Immune Defic Syndr. 2020;84:S49–55.
· extracted · source:references/10665-340190.sec-021.20.jsonKatirayi L, Ochuka B, Mafaune H, Chadambuka A, Baffour T, Sacks E. “We need it the same day”: a qualitative study of caregivers and community members’ perspectives toward the use of point-of-care early infant diagnosis. J Acquir Immune Defic Syndr. 2020;84:S49–55.
- Issued
- 2020
- Type
- article-journal
- As printed
- Katirayi L, Ochuka B, Mafaune H, Chadambuka A, Baffour T, Sacks E. “We need it the same day”: a qualitative study of caregivers and community members’ perspectives toward the use of point-of-care early infant diagnosis. J Acquir Immune Defic Syndr. 2020;84:S49–55.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.20 - provenance: extracted
- read from
references/10665-340190.sec-021.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Bianchi F, Clemens S, Arif Z, Sacks E, Cohn J. Acceptability of routine point-of-care early infant diagnosis in eight African countries: findings from a qualitative assessment of clinical and laboratory personnel. J Acquir Immune Defic Syndr. 2020;84:S41–8.
· extracted · source:references/10665-340190.sec-021.21.jsonBianchi F, Clemens S, Arif Z, Sacks E, Cohn J. Acceptability of routine point-of-care early infant diagnosis in eight African countries: findings from a qualitative assessment of clinical and laboratory personnel. J Acquir Immune Defic Syndr. 2020;84:S41–8.
- Issued
- 2020
- Type
- article-journal
- As printed
- Bianchi F, Clemens S, Arif Z, Sacks E, Cohn J. Acceptability of routine point-of-care early infant diagnosis in eight African countries: findings from a qualitative assessment of clinical and laboratory personnel. J Acquir Immune Defic Syndr. 2020;84:S41–8.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.21 - provenance: extracted
- read from
references/10665-340190.sec-021.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Ochodo EA, Guleid F, Mallett S, Deeks JJ. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2018;(1):CD013207.
· extracted · source:references/10665-340190.sec-021.22.jsonOchodo EA, Guleid F, Mallett S, Deeks JJ. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2018;(1):CD013207.
- Issued
- 2018
- Type
- document
- As printed
- Ochodo EA, Guleid F, Mallett S, Deeks JJ. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV infection in infants and children aged 18 months or less. Cochrane Database Syst Rev. 2018;(1):CD013207.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.22 - provenance: extracted
- read from
references/10665-340190.sec-021.22.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Silva DS. Ethical and equity considerations regarding the potential future implementation of HIV/AIDS novel diagnostics. [See Web Annex C.2].
· extracted · source:references/10665-340190.sec-021.23.jsonSilva DS. Ethical and equity considerations regarding the potential future implementation of HIV/AIDS novel diagnostics. [See Web Annex C.2].
- Type
- document
- As printed
- Silva DS. Ethical and equity considerations regarding the potential future implementation of HIV/AIDS novel diagnostics. [See Web Annex C.2].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.23 - provenance: extracted
- read from
references/10665-340190.sec-021.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: World Health Organization; 2018 (https://www.who.int/hiv/pub/paediatric/diagnosis-arv-infants/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.24.jsonHIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: World Health Organization; 2018 (https://www.who.int/hiv/pub/paediatric/diagnosis-arv-infants/en, accessed 4 February 2021).
- Issued
- 2018
- Type
- document
- Accessed
- 4 February 2021
- As printed
- HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: World Health Organization; 2018 (https://www.who.int/hiv/pub/paediatric/diagnosis-arv-infants/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.24 - provenance: extracted
- read from
references/10665-340190.sec-021.24.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
HIV market report. Boston: Clinton Health Access Initiative; 2020 (Issue 11). (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, Accessed 1 March 2021).
· extracted · link · source:references/10665-340190.sec-021.25.jsonHIV market report. Boston: Clinton Health Access Initiative; 2020 (Issue 11). (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, Accessed 1 March 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 1 March 2021
- As printed
- HIV market report. Boston: Clinton Health Access Initiative; 2020 (Issue 11). (https://www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/, Accessed 1 March 2021).
Sources
- www.clintonhealthaccess.org/the-state-of-the-hiv-market-in-low-and-middle-income-countries-3/ (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-021.25 - provenance: extracted
- read from
references/10665-340190.sec-021.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
WHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.26.jsonWHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- WHO list of prequalified in vitro diagnostic products. Geneva: World Health Organization; 2020 (https://www.who.int/diagnostics_laboratory/evaluations/pq-list/hiv-vrl/public_report/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.26 - provenance: extracted
- read from
references/10665-340190.sec-021.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Le Roux S, Myer L, Vojnov L. Clinical and operational impact of point-of-care compared to laboratory-based nucleic acid testing for routine HIV viral load monitoring: a systematic review and meta-analysis. In preparation. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-021.27.jsonLe Roux S, Myer L, Vojnov L. Clinical and operational impact of point-of-care compared to laboratory-based nucleic acid testing for routine HIV viral load monitoring: a systematic review and meta-analysis. In preparation. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Le Roux S, Myer L, Vojnov L. Clinical and operational impact of point-of-care compared to laboratory-based nucleic acid testing for routine HIV viral load monitoring: a systematic review and meta-analysis. In preparation. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.27 - provenance: extracted
- read from
references/10665-340190.sec-021.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N et al. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (stream): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020;7:e229–37.
· extracted · source:references/10665-340190.sec-021.28.jsonDrain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N et al. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (stream): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020;7:e229–37.
- Issued
- 2020
- Type
- article-journal
- As printed
- Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N et al. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (stream): findings from an open-label, non-inferiority, randomised controlled trial. Lancet HIV. 2020;7:e229–37.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.28 - provenance: extracted
- read from
references/10665-340190.sec-021.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Boeke CE, Joseph J, Atem C, Banda C, Coulibaly KD, Doi N, Gunda A, Kandulu J, Kiernan B, Kingwara L, Maokola W. Evaluation of near point‐of‐care viral load implementation in public health facilities across seven countries in sub‐Saharan Africa. Journal of the International AIDS Society. 2021 Jan;24(1):e25663.
· extracted · source:references/10665-340190.sec-021.29.jsonBoeke CE, Joseph J, Atem C, Banda C, Coulibaly KD, Doi N, Gunda A, Kandulu J, Kiernan B, Kingwara L, Maokola W. Evaluation of near point‐of‐care viral load implementation in public health facilities across seven countries in sub‐Saharan Africa. Journal of the International AIDS Society. 2021 Jan;24(1):e25663.
- Issued
- 2021
- Type
- document
- As printed
- Boeke CE, Joseph J, Atem C, Banda C, Coulibaly KD, Doi N, Gunda A, Kandulu J, Kiernan B, Kingwara L, Maokola W. Evaluation of near point‐of‐care viral load implementation in public health facilities across seven countries in sub‐Saharan Africa. Journal of the International AIDS Society. 2021 Jan;24(1):e25663.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.29 - provenance: extracted
- read from
references/10665-340190.sec-021.29.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Ndlovu Z, Fajardo E, Mbofana E, Maparo T, Garone D, Metcalf C et al. Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe. PLoS One. 2018;13:e0193577.
· extracted · source:references/10665-340190.sec-021.30.jsonNdlovu Z, Fajardo E, Mbofana E, Maparo T, Garone D, Metcalf C et al. Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe. PLoS One. 2018;13:e0193577.
- Issued
- 2018
- Type
- article-journal
- As printed
- Ndlovu Z, Fajardo E, Mbofana E, Maparo T, Garone D, Metcalf C et al. Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe. PLoS One. 2018;13:e0193577.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.30 - provenance: extracted
- read from
references/10665-340190.sec-021.30.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Mangone E, Cintron C, Haider R, Johns B, Avila C, Vartanova Y. Cost–effectiveness analysis of nationally scaled point-of-care diagnostic platforms compared to central laboratory models for routine viral load monitoring of HIV-positive Kenyans on antiretroviral therapy. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018.
· extracted · source:references/10665-340190.sec-021.31.jsonMangone E, Cintron C, Haider R, Johns B, Avila C, Vartanova Y. Cost–effectiveness analysis of nationally scaled point-of-care diagnostic platforms compared to central laboratory models for routine viral load monitoring of HIV-positive Kenyans on antiretroviral therapy. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018.
- Issued
- 2018
- Type
- document
- As printed
- Mangone E, Cintron C, Haider R, Johns B, Avila C, Vartanova Y. Cost–effectiveness analysis of nationally scaled point-of-care diagnostic platforms compared to central laboratory models for routine viral load monitoring of HIV-positive Kenyans on antiretroviral therapy. 22nd International AIDS Society Conference, Amsterdam, Netherlands, 23–27 July 2018.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.31 - provenance: extracted
- read from
references/10665-340190.sec-021.31.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
de Necker M, de Beer JC, Stander MP, Connell CD, Mwai D. Economic and public health impact of decentralized HIV viral load testing: a modelling study in Kenya. PLoS One. 2019;14:e0212972.
· extracted · source:references/10665-340190.sec-021.32.jsonde Necker M, de Beer JC, Stander MP, Connell CD, Mwai D. Economic and public health impact of decentralized HIV viral load testing: a modelling study in Kenya. PLoS One. 2019;14:e0212972.
- Issued
- 2019
- Type
- article-journal
- As printed
- de Necker M, de Beer JC, Stander MP, Connell CD, Mwai D. Economic and public health impact of decentralized HIV viral load testing: a modelling study in Kenya. PLoS One. 2019;14:e0212972.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.32 - provenance: extracted
- read from
references/10665-340190.sec-021.32.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Girdwood S Crompton T, Sharma M, Dorward J, Garrett N, Drain PK et al. Cost– effectiveness of adoption strategies for point-of-care HIV viral load monitoring in South Africa. EClinicalMedicine. 2020;28:100607.
· extracted · source:references/10665-340190.sec-021.33.jsonGirdwood S Crompton T, Sharma M, Dorward J, Garrett N, Drain PK et al. Cost– effectiveness of adoption strategies for point-of-care HIV viral load monitoring in South Africa. EClinicalMedicine. 2020;28:100607.
- Issued
- 2020
- Type
- article-journal
- As printed
- Girdwood S Crompton T, Sharma M, Dorward J, Garrett N, Drain PK et al. Cost– effectiveness of adoption strategies for point-of-care HIV viral load monitoring in South Africa. EClinicalMedicine. 2020;28:100607.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.33 - provenance: extracted
- read from
references/10665-340190.sec-021.33.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Bwana P, Ageng’o J, Danda J, Mbugua J, Handa A, Mwau M. Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya. J Clin Virol. 2019;121:104202.
· extracted · source:references/10665-340190.sec-021.34.jsonBwana P, Ageng’o J, Danda J, Mbugua J, Handa A, Mwau M. Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya. J Clin Virol. 2019;121:104202.
- Issued
- 2019
- Type
- article-journal
- As printed
- Bwana P, Ageng’o J, Danda J, Mbugua J, Handa A, Mwau M. Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya. J Clin Virol. 2019;121:104202.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.34 - provenance: extracted
- read from
references/10665-340190.sec-021.34.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Bwana P, Ageng’o J, Mwau M. Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya. PLoS One. 2019;14:e0213865.
· extracted · source:references/10665-340190.sec-021.35.jsonBwana P, Ageng’o J, Mwau M. Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya. PLoS One. 2019;14:e0213865.
- Issued
- 2019
- Type
- article-journal
- As printed
- Bwana P, Ageng’o J, Mwau M. Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya. PLoS One. 2019;14:e0213865.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.35 - provenance: extracted
- read from
references/10665-340190.sec-021.35.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Habiyambere V, Ford N, Low-Beer D, Nkengasong J, Sands A, Pérez González M et al. Availability and use of HIV monitoring and early infant diagnosis technologies in WHO Member States in 2011–2013: analysis of annual surveys at the facility level. PLoS Med. 2016;13:e1002088.
· extracted · source:references/10665-340190.sec-021.36.jsonHabiyambere V, Ford N, Low-Beer D, Nkengasong J, Sands A, Pérez González M et al. Availability and use of HIV monitoring and early infant diagnosis technologies in WHO Member States in 2011–2013: analysis of annual surveys at the facility level. PLoS Med. 2016;13:e1002088.
- Issued
- 2016
- Type
- article-journal
- As printed
- Habiyambere V, Ford N, Low-Beer D, Nkengasong J, Sands A, Pérez González M et al. Availability and use of HIV monitoring and early infant diagnosis technologies in WHO Member States in 2011–2013: analysis of annual surveys at the facility level. PLoS Med. 2016;13:e1002088.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.36 - provenance: extracted
- read from
references/10665-340190.sec-021.36.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Kufa T, Mazanderani AH, Sherman GG, Mukendi A, Murray T, Moyo F et al. Point‐of‐care HIV maternal viral load and early infant diagnosis testing around time of delivery at tertiary obstetric units in South Africa: a prospective study of coverage, results return and turn‐ around times. J Int AIDS Soc. 2020;23:e25487.
· extracted · source:references/10665-340190.sec-021.37.jsonKufa T, Mazanderani AH, Sherman GG, Mukendi A, Murray T, Moyo F et al. Point‐of‐care HIV maternal viral load and early infant diagnosis testing around time of delivery at tertiary obstetric units in South Africa: a prospective study of coverage, results return and turn‐ around times. J Int AIDS Soc. 2020;23:e25487.
- Issued
- 2020
- Type
- article-journal
- As printed
- Kufa T, Mazanderani AH, Sherman GG, Mukendi A, Murray T, Moyo F et al. Point‐of‐care HIV maternal viral load and early infant diagnosis testing around time of delivery at tertiary obstetric units in South Africa: a prospective study of coverage, results return and turn‐ around times. J Int AIDS Soc. 2020;23:e25487.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.37 - provenance: extracted
- read from
references/10665-340190.sec-021.37.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Mashamba-Thompson T, Sartorius B, Drain P. Operational assessment of point-of-care diagnostics in rural primary healthcare clinics of KwaZulu-Natal, South Africa: a cross-sectional survey. BMC Health Serv Res. 2018;18:380.
· extracted · source:references/10665-340190.sec-021.38.jsonMashamba-Thompson T, Sartorius B, Drain P. Operational assessment of point-of-care diagnostics in rural primary healthcare clinics of KwaZulu-Natal, South Africa: a cross-sectional survey. BMC Health Serv Res. 2018;18:380.
- Issued
- 2018
- Type
- article-journal
- As printed
- Mashamba-Thompson T, Sartorius B, Drain P. Operational assessment of point-of-care diagnostics in rural primary healthcare clinics of KwaZulu-Natal, South Africa: a cross-sectional survey. BMC Health Serv Res. 2018;18:380.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.38 - provenance: extracted
- read from
references/10665-340190.sec-021.38.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I et al. Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi. J Int AIDS Soc. 2019;22:e25387.
· extracted · source:references/10665-340190.sec-021.39.jsonNicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I et al. Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi. J Int AIDS Soc. 2019;22:e25387.
- Issued
- 2019
- Type
- article-journal
- As printed
- Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I et al. Point‐of‐care viral load monitoring: outcomes from a decentralized HIV programme in Malawi. J Int AIDS Soc. 2019;22:e25387.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.39 - provenance: extracted
- read from
references/10665-340190.sec-021.39.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
· extracted · source:references/10665-340190.sec-021.40.jsonVilla G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
- Issued
- 2020
- Type
- article-journal
- As printed
- Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.40 - provenance: extracted
- read from
references/10665-340190.sec-021.40.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Making viral load routine: successes and failures in the implementation of routine HIV viral load monitoring Geneva: Médecins Sans Frontières; 2016.
· extracted · source:references/10665-340190.sec-021.41.jsonMaking viral load routine: successes and failures in the implementation of routine HIV viral load monitoring Geneva: Médecins Sans Frontières; 2016.
- Issued
- 2016
- Type
- document
- As printed
- Making viral load routine: successes and failures in the implementation of routine HIV viral load monitoring Geneva: Médecins Sans Frontières; 2016.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.41 - provenance: extracted
- read from
references/10665-340190.sec-021.41.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Sacks JA, Fong Y, Gonzalez MP, Andreotti M, Baliga S, Garrett N et al. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS. 2019;33:1881–9.
· extracted · source:references/10665-340190.sec-021.42.jsonSacks JA, Fong Y, Gonzalez MP, Andreotti M, Baliga S, Garrett N et al. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS. 2019;33:1881–9.
- Issued
- 2019
- Type
- article-journal
- As printed
- Sacks JA, Fong Y, Gonzalez MP, Andreotti M, Baliga S, Garrett N et al. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS. 2019;33:1881–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.42 - provenance: extracted
- read from
references/10665-340190.sec-021.42.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Mariani D, de Azevedo M, Vasconcellos I, Ribeiro L, Alves C, Ferreira Jr OC et al. The performance of a new point-of-care HIV virus load technology to identify patients failing antiretroviral treatment. J Clin Virol. 2020;122:104212.
· extracted · source:references/10665-340190.sec-021.43.jsonMariani D, de Azevedo M, Vasconcellos I, Ribeiro L, Alves C, Ferreira Jr OC et al. The performance of a new point-of-care HIV virus load technology to identify patients failing antiretroviral treatment. J Clin Virol. 2020;122:104212.
- Issued
- 2020
- Type
- article-journal
- As printed
- Mariani D, de Azevedo M, Vasconcellos I, Ribeiro L, Alves C, Ferreira Jr OC et al. The performance of a new point-of-care HIV virus load technology to identify patients failing antiretroviral treatment. J Clin Virol. 2020;122:104212.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.43 - provenance: extracted
- read from
references/10665-340190.sec-021.43.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Cepheid’s HBDC (High Burden Developing Country program). Sunnyvale (CA) Cepheid Subsidary, Danaher Corporation; 2011 (https://www.cepheidlegacy.com/uk/cepheid-solutions/hbdc-program#:~:text=Cepheid%20is%20an%20active%20participant,Melinda%20Gates%20Foundation%20and%20others, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.44.jsonCepheid’s HBDC (High Burden Developing Country program). Sunnyvale (CA) Cepheid Subsidary, Danaher Corporation; 2011 (https://www.cepheidlegacy.com/uk/cepheid-solutions/hbdc-program#:~:text=Cepheid%20is%20an%20active%20participant,Melinda%20Gates%20Foundation%20and%20others, accessed 4 February 2021).
- Issued
- 2011
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Cepheid’s HBDC (High Burden Developing Country program). Sunnyvale (CA) Cepheid Subsidary, Danaher Corporation; 2011 (https://www.cepheidlegacy.com/uk/cepheid-solutions/hbdc-program#:~:text=Cepheid%20is%20an%20active%20participant,Melinda%20Gates%20Foundation%20and%20others, accessed 4 February 2021).
Sources
- www.cepheidlegacy.com/uk/cepheid-solutions/hbdc-program#:~:text=Cepheid%20is%20an%20active%20participant (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-021.44 - provenance: extracted
- read from
references/10665-340190.sec-021.44.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Update of recommendations on first- and second-line antiretroviral regimens. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/, accessed 4 February 2021).).
· extracted · link · source:references/10665-340190.sec-021.45.jsonUpdate of recommendations on first- and second-line antiretroviral regimens. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/, accessed 4 February 2021).).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Update of recommendations on first- and second-line antiretroviral regimens. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/, accessed 4 February 2021).).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.45 - provenance: extracted
- read from
references/10665-340190.sec-021.45.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
HIV drug resistance report 2019. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.46.jsonHIV drug resistance report 2019. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en, accessed 4 February 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- HIV drug resistance report 2019. Geneva: World Health Organization; 2019 (https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.46 - provenance: extracted
- read from
references/10665-340190.sec-021.46.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Broyles LN, Boeras D, Luo R, Vojnov L. The viral load monitoring algorithm in people living with HIV on antiretroviral therapy: review of the literature to inform the WHO HIV guidelines. Unpublished. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-021.47.jsonBroyles LN, Boeras D, Luo R, Vojnov L. The viral load monitoring algorithm in people living with HIV on antiretroviral therapy: review of the literature to inform the WHO HIV guidelines. Unpublished. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Broyles LN, Boeras D, Luo R, Vojnov L. The viral load monitoring algorithm in people living with HIV on antiretroviral therapy: review of the literature to inform the WHO HIV guidelines. Unpublished. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.47 - provenance: extracted
- read from
references/10665-340190.sec-021.47.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE et al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet. 2019;393:143–55.
· extracted · source:references/10665-340190.sec-021.48.jsonCahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE et al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet. 2019;393:143–55.
- Issued
- 2019
- Type
- article-journal
- As printed
- Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE et al. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet. 2019;393:143–55.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.48 - provenance: extracted
- read from
references/10665-340190.sec-021.48.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381:803–15.
· extracted · source:references/10665-340190.sec-021.49.jsonVenter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381:803–15.
- Issued
- 2019
- Type
- article-journal
- As printed
- Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med. 2019;381:803–15.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.49 - provenance: extracted
- read from
references/10665-340190.sec-021.49.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
The NAMSAL ANRS 12313 Study Group. Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1. N Engl J Med. 2019;381:816–26.
· extracted · source:references/10665-340190.sec-021.50.jsonThe NAMSAL ANRS 12313 Study Group. Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1. N Engl J Med. 2019;381:816–26.
- Issued
- 2019
- Type
- article-journal
- As printed
- The NAMSAL ANRS 12313 Study Group. Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1. N Engl J Med. 2019;381:816–26.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.50 - provenance: extracted
- read from
references/10665-340190.sec-021.50.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Sax PE, Pozniak A, Montes ML, Koenig E, DeJesus E, Stellbrink HJ et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017;390:2073–82.
· extracted · source:references/10665-340190.sec-021.51.jsonSax PE, Pozniak A, Montes ML, Koenig E, DeJesus E, Stellbrink HJ et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017;390:2073–82.
- Issued
- 2017
- Type
- article-journal
- As printed
- Sax PE, Pozniak A, Montes ML, Koenig E, DeJesus E, Stellbrink HJ et al. Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet. 2017;390:2073–82.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.51 - provenance: extracted
- read from
references/10665-340190.sec-021.51.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Rossetti B, Baldin G, Sterrantino G, Rusconi S, De Vito A, Giacometti A et al. Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicentre cohort study. Antiviral Res. 2019;169:104552.
· extracted · source:references/10665-340190.sec-021.52.jsonRossetti B, Baldin G, Sterrantino G, Rusconi S, De Vito A, Giacometti A et al. Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicentre cohort study. Antiviral Res. 2019;169:104552.
- Issued
- 2019
- Type
- article-journal
- As printed
- Rossetti B, Baldin G, Sterrantino G, Rusconi S, De Vito A, Giacometti A et al. Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicentre cohort study. Antiviral Res. 2019;169:104552.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.52 - provenance: extracted
- read from
references/10665-340190.sec-021.52.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I et al. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48-week results from the randomised open-label Phase 3b study. Lancet. 2014;383:2222–31.
· extracted · source:references/10665-340190.sec-021.53.jsonClotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I et al. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48-week results from the randomised open-label Phase 3b study. Lancet. 2014;383:2222–31.
- Issued
- 2014
- Type
- article-journal
- As printed
- Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I et al. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48-week results from the randomised open-label Phase 3b study. Lancet. 2014;383:2222–31.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.53 - provenance: extracted
- read from
references/10665-340190.sec-021.53.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
ARROW Trial Team. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381:1391–403.
· extracted · source:references/10665-340190.sec-021.54.jsonARROW Trial Team. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381:1391–403.
- Issued
- 2013
- Type
- article-journal
- As printed
- ARROW Trial Team. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial. Lancet. 2013;381:1391–403.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.54 - provenance: extracted
- read from
references/10665-340190.sec-021.54.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P et al. Nevirapine versus rtonavir-boosted lopinavir for HIV-infected children. N Engl J Med. 2012;366:2380–9.
· extracted · source:references/10665-340190.sec-021.55.jsonViolari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P et al. Nevirapine versus rtonavir-boosted lopinavir for HIV-infected children. N Engl J Med. 2012;366:2380–9.
- Issued
- 2012
- Type
- article-journal
- As printed
- Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P et al. Nevirapine versus rtonavir-boosted lopinavir for HIV-infected children. N Engl J Med. 2012;366:2380–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.55 - provenance: extracted
- read from
references/10665-340190.sec-021.55.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Gregson J, Tang M, Ndembi N, Hamers RL, Rhee SY, Marconi VC et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16:565–75.
· extracted · source:references/10665-340190.sec-021.56.jsonGregson J, Tang M, Ndembi N, Hamers RL, Rhee SY, Marconi VC et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16:565–75.
- Issued
- 2016
- Type
- article-journal
- As printed
- Gregson J, Tang M, Ndembi N, Hamers RL, Rhee SY, Marconi VC et al. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016;16:565–75.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.56 - provenance: extracted
- read from
references/10665-340190.sec-021.56.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Hamers RL, Sigaloff KCE, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K et al. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. Clin Infect Dis. 2012;54:1660–9.
· extracted · source:references/10665-340190.sec-021.57.jsonHamers RL, Sigaloff KCE, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K et al. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. Clin Infect Dis. 2012;54:1660–9.
- Issued
- 2012
- Type
- article-journal
- As printed
- Hamers RL, Sigaloff KCE, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K et al. Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies. Clin Infect Dis. 2012;54:1660–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.57 - provenance: extracted
- read from
references/10665-340190.sec-021.57.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Ford N, Orrell C, Shubber Z, Apollo T, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22:e25415.
· extracted · source:references/10665-340190.sec-021.58.jsonFord N, Orrell C, Shubber Z, Apollo T, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22:e25415.
- Issued
- 2019
- Type
- article-journal
- As printed
- Ford N, Orrell C, Shubber Z, Apollo T, Vojnov L. HIV viral resuppression following an elevated viral load: a systematic review and meta-analysis. J Int AIDS Soc. 2019;22:e25415.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.58 - provenance: extracted
- read from
references/10665-340190.sec-021.58.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
· extracted · source:references/10665-340190.sec-021.59.jsonVilla G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
- Issued
- 2020
- Type
- article-journal
- As printed
- Villa G, Abdullahi A, Owusu D, Smith C, Azumah M, Sayeed L et al. Determining virological sub-Saharan Africa. EClinicalMedicine. 2020;18:100231.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.59 - provenance: extracted
- read from
references/10665-340190.sec-021.59.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C et al. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda. HIV Med. 2020;21:21–9.
· extracted · source:references/10665-340190.sec-021.60.jsonBirungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C et al. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda. HIV Med. 2020;21:21–9.
- Issued
- 2020
- Type
- article-journal
- As printed
- Birungi J, Cui Z, Okoboi S, Kapaata A, Munderi P, Mukajjanga C et al. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda. HIV Med. 2020;21:21–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.60 - provenance: extracted
- read from
references/10665-340190.sec-021.60.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Hermans LE, Carmona S, Nijhuis M, Tempelman HA, Richman DD, Moorhouse M et al. Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study. PLoS Med. 2020;17:e1003037.
· extracted · source:references/10665-340190.sec-021.61.jsonHermans LE, Carmona S, Nijhuis M, Tempelman HA, Richman DD, Moorhouse M et al. Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study. PLoS Med. 2020;17:e1003037.
- Issued
- 2020
- Type
- article-journal
- As printed
- Hermans LE, Carmona S, Nijhuis M, Tempelman HA, Richman DD, Moorhouse M et al. Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study. PLoS Med. 2020;17:e1003037.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.61 - provenance: extracted
- read from
references/10665-340190.sec-021.61.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
De Luca A, Sidumo ZJ, Zanelli G, Magid NA, Luhanga R, Brambilla D et al. Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique. BMC Infect Dis. 2017;17:1–6.
· extracted · source:references/10665-340190.sec-021.62.jsonDe Luca A, Sidumo ZJ, Zanelli G, Magid NA, Luhanga R, Brambilla D et al. Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique. BMC Infect Dis. 2017;17:1–6.
- Issued
- 2017
- Type
- article-journal
- As printed
- De Luca A, Sidumo ZJ, Zanelli G, Magid NA, Luhanga R, Brambilla D et al. Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique. BMC Infect Dis. 2017;17:1–6.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.62 - provenance: extracted
- read from
references/10665-340190.sec-021.62.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Values and preferences survey to inform the development of the Guideline on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring. Geneva: World Health Organization. [See Web Annex C.3].
· extracted · source:references/10665-340190.sec-021.63.jsonValues and preferences survey to inform the development of the Guideline on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring. Geneva: World Health Organization. [See Web Annex C.3].
- Type
- document
- As printed
- Values and preferences survey to inform the development of the Guideline on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring. Geneva: World Health Organization. [See Web Annex C.3].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.63 - provenance: extracted
- read from
references/10665-340190.sec-021.63.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Phillips A, Bansi-Matharu L, Cambiano V, HIV Modelling Consortium. Modelled evaluation of modifications in viral load monitoring in the context of sub-Saharan Africa: modelling to inform WHO guidance. (https://doi.org/10.6084/m9.figshare.13259219.v1, accessed 9 February 2021).
· extracted · doi:10.6084/m9.figshare.13259219.v1 · source:references/10665-340190.sec-021.64.jsonPhillips A, Bansi-Matharu L, Cambiano V, HIV Modelling Consortium. Modelled evaluation of modifications in viral load monitoring in the context of sub-Saharan Africa: modelling to inform WHO guidance. (https://doi.org/10.6084/m9.figshare.13259219.v1, accessed 9 February 2021).
- Type
- document
- DOI
- 10.6084/m9.figshare.13259219.v1
- Accessed
- 9 February 2021
- As printed
- Phillips A, Bansi-Matharu L, Cambiano V, HIV Modelling Consortium. Modelled evaluation of modifications in viral load monitoring in the context of sub-Saharan Africa: modelling to inform WHO guidance. (https://doi.org/10.6084/m9.figshare.13259219.v1, accessed 9 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.64 - provenance: extracted
- read from
references/10665-340190.sec-021.64.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Shroufi A, Van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, Murphy RA et al. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure. AIDS. 2019;33:1635–44.
· extracted · source:references/10665-340190.sec-021.65.jsonShroufi A, Van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, Murphy RA et al. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure. AIDS. 2019;33:1635–44.
- Issued
- 2019
- Type
- article-journal
- As printed
- Shroufi A, Van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, Murphy RA et al. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure. AIDS. 2019;33:1635–44.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.65 - provenance: extracted
- read from
references/10665-340190.sec-021.65.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-021.66.jsonHIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
- Issued
- 2019
- Type
- document
- Accessed
- 4 February 2021
- As printed
- HIV molecular diagnostics toolkit to improve access to viral load testing and infant diagnosis. Geneva: World Health Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/325961/9789241516211-eng.pdf, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-021.66 - provenance: extracted
- read from
references/10665-340190.sec-021.66.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Luo R, Boeras D, Broyles L, Vojnov L. Systematic review of the HIV viral load threshold for treatment failure: impacts on disease progression, drug resistance, and HIV transmission. In preparation. [Abstract available in Web Annex C.1].
· extracted · source:references/10665-340190.sec-021.67.jsonLuo R, Boeras D, Broyles L, Vojnov L. Systematic review of the HIV viral load threshold for treatment failure: impacts on disease progression, drug resistance, and HIV transmission. In preparation. [Abstract available in Web Annex C.1].
- Type
- document
- As printed
- Luo R, Boeras D, Broyles L, Vojnov L. Systematic review of the HIV viral load threshold for treatment failure: impacts on disease progression, drug resistance, and HIV transmission. In preparation. [Abstract available in Web Annex C.1].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.67 - provenance: extracted
- read from
references/10665-340190.sec-021.67.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Mofenson L. Mother-to-child transmission review. Unpublished. 2020.
· extracted · source:references/10665-340190.sec-021.68.jsonMofenson L. Mother-to-child transmission review. Unpublished. 2020.
- Issued
- 2020
- Type
- document
- As printed
- Mofenson L. Mother-to-child transmission review. Unpublished. 2020.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.68 - provenance: extracted
- read from
references/10665-340190.sec-021.68.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Vojnov L, Fong Y, Prescott M, Ford N, Carmona S, Zeh C et al. A meta-analysis of using dried blood spots for viral load testing with lower treatment failure thresholds. Submitted.
· extracted · source:references/10665-340190.sec-021.69.jsonVojnov L, Fong Y, Prescott M, Ford N, Carmona S, Zeh C et al. A meta-analysis of using dried blood spots for viral load testing with lower treatment failure thresholds. Submitted.
- Type
- document
- As printed
- Vojnov L, Fong Y, Prescott M, Ford N, Carmona S, Zeh C et al. A meta-analysis of using dried blood spots for viral load testing with lower treatment failure thresholds. Submitted.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.69 - provenance: extracted
- read from
references/10665-340190.sec-021.69.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Vojnov L, Carmona S, Zeh C, Markby J, Boeras D, Prescott MR et al. Dried blood spot samples for viral load testing can be used with most currently available viral load technologies: a pooled data meta-analysis. Submitted.
· extracted · source:references/10665-340190.sec-021.70.jsonVojnov L, Carmona S, Zeh C, Markby J, Boeras D, Prescott MR et al. Dried blood spot samples for viral load testing can be used with most currently available viral load technologies: a pooled data meta-analysis. Submitted.
- Type
- document
- As printed
- Vojnov L, Carmona S, Zeh C, Markby J, Boeras D, Prescott MR et al. Dried blood spot samples for viral load testing can be used with most currently available viral load technologies: a pooled data meta-analysis. Submitted.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-021.70 - provenance: extracted
- read from
references/10665-340190.sec-021.70.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-021-references.md
-
Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.1.jsonGlobal tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
Sources
- www.who.int/publications/i/item/9789240013131 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-025.1 - provenance: extracted
- read from
references/10665-340190.sec-025.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.2.jsonConsolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
- Issued
- 2016
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach – second edition. Geneva: World Health Organization; 2016 (https://www.who.int/hiv/pub/arv/arv-2016/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/arv/arv-2016/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-025.2 - provenance: extracted
- read from
references/10665-340190.sec-025.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.3.jsonGuidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-025.3 - provenance: extracted
- read from
references/10665-340190.sec-025.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Sinha S, Shekhar RC, Singh G, Shah N, Ahmad H, Kumar N et al. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment. BMC Infect Dis. 2012;12:1–9.
· extracted · source:references/10665-340190.sec-025.4.jsonSinha S, Shekhar RC, Singh G, Shah N, Ahmad H, Kumar N et al. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment. BMC Infect Dis. 2012;12:1–9.
- Issued
- 2012
- Type
- article-journal
- As printed
- Sinha S, Shekhar RC, Singh G, Shah N, Ahmad H, Kumar N et al. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment. BMC Infect Dis. 2012;12:1–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.4 - provenance: extracted
- read from
references/10665-340190.sec-025.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014;14:563–71.
· extracted · source:references/10665-340190.sec-025.5.jsonMfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014;14:563–71.
- Issued
- 2014
- Type
- article-journal
- As printed
- Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G et al. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis. 2014;14:563–71.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.5 - provenance: extracted
- read from
references/10665-340190.sec-025.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Amogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A et al. Efficacy and safety of antiretroviral therapy initiated one week after tuberculosis therapy in patients with CD4 counts <200 cells/μL: TB-HAART Study, a randomized clinical trial. PLoS One. 2015;10:e0122587.
· extracted · source:references/10665-340190.sec-025.6.jsonAmogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A et al. Efficacy and safety of antiretroviral therapy initiated one week after tuberculosis therapy in patients with CD4 counts <200 cells/μL: TB-HAART Study, a randomized clinical trial. PLoS One. 2015;10:e0122587.
- Issued
- 2015
- Type
- article-journal
- As printed
- Amogne W, Aderaye G, Habtewold A, Yimer G, Makonnen E, Worku A et al. Efficacy and safety of antiretroviral therapy initiated one week after tuberculosis therapy in patients with CD4 counts <200 cells/μL: TB-HAART Study, a randomized clinical trial. PLoS One. 2015;10:e0122587.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.6 - provenance: extracted
- read from
references/10665-340190.sec-025.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Merle CS, Floyd S, Ndiaye A, Galperine T, Furco A, De Jong BC et al. High-dose rifampicin tuberculosis treatment regimen to reduce 12-month mortality of TB/HIV co-infected patients: the RAFA trial results. J Int AIDS Soc. 2016;19:38–9.
· extracted · source:references/10665-340190.sec-025.7.jsonMerle CS, Floyd S, Ndiaye A, Galperine T, Furco A, De Jong BC et al. High-dose rifampicin tuberculosis treatment regimen to reduce 12-month mortality of TB/HIV co-infected patients: the RAFA trial results. J Int AIDS Soc. 2016;19:38–9.
- Issued
- 2016
- Type
- article-journal
- As printed
- Merle CS, Floyd S, Ndiaye A, Galperine T, Furco A, De Jong BC et al. High-dose rifampicin tuberculosis treatment regimen to reduce 12-month mortality of TB/HIV co-infected patients: the RAFA trial results. J Int AIDS Soc. 2016;19:38–9.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.7 - provenance: extracted
- read from
references/10665-340190.sec-025.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Shao HJ, Crump JA, Ramadhani HO, Uiso LO, Ole-Nguyaine S, Moon AM et al. Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses. 2009;25:1277–85.
· extracted · source:references/10665-340190.sec-025.8.jsonShao HJ, Crump JA, Ramadhani HO, Uiso LO, Ole-Nguyaine S, Moon AM et al. Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses. 2009;25:1277–85.
- Issued
- 2009
- Type
- article-journal
- As printed
- Shao HJ, Crump JA, Ramadhani HO, Uiso LO, Ole-Nguyaine S, Moon AM et al. Early versus delayed fixed dose combination abacavir/lamivudine/zidovudine in patients with HIV and tuberculosis in Tanzania. AIDS Res Hum Retroviruses. 2009;25:1277–85.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.8 - provenance: extracted
- read from
references/10665-340190.sec-025.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697– 706.
· extracted · source:references/10665-340190.sec-025.9.jsonAbdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697– 706.
- Issued
- 2010
- Type
- article-journal
- As printed
- Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362:697– 706.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.9 - provenance: extracted
- read from
references/10665-340190.sec-025.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501.
· extracted · source:references/10665-340190.sec-025.10.jsonAbdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501.
- Issued
- 2011
- Type
- article-journal
- As printed
- Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492–501.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.10 - provenance: extracted
- read from
references/10665-340190.sec-025.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482–91.
· extracted · source:references/10665-340190.sec-025.11.jsonHavlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482–91.
- Issued
- 2011
- Type
- article-journal
- As printed
- Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482–91.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.11 - provenance: extracted
- read from
references/10665-340190.sec-025.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471–81.
· extracted · source:references/10665-340190.sec-025.12.jsonBlanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471–81.
- Issued
- 2011
- Type
- article-journal
- As printed
- Blanc F-X, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471–81.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.12 - provenance: extracted
- read from
references/10665-340190.sec-025.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Merle C. RAFA trial sub-analysis. In preparation.
· extracted · source:references/10665-340190.sec-025.13.jsonMerle C. RAFA trial sub-analysis. In preparation.
- Type
- document
- As printed
- Merle C. RAFA trial sub-analysis. In preparation.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.13 - provenance: extracted
- read from
references/10665-340190.sec-025.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Dooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M et al. Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial. Clin Infect Dis. 2020;70·549–56.
· extracted · source:references/10665-340190.sec-025.14.jsonDooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M et al. Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial. Clin Infect Dis. 2020;70·549–56.
- Issued
- 2020
- Type
- document
- As printed
- Dooley KE, Kaplan R, Mwelase N, Grinsztejn B, Ticona E, Lacerda M et al. Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial. Clin Infect Dis. 2020;70·549–56.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.14 - provenance: extracted
- read from
references/10665-340190.sec-025.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Kanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020:100573. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
· extracted · source:references/10665-340190.sec-025.15.jsonKanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020:100573. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
- Issued
- 2020
- Type
- document
- As printed
- Kanters S, Vitoria M, Zoratti M, Doherty M, Penazzato M, Rangaraj A et al. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis. EClinicalMedicine. 2020:100573. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.15 - provenance: extracted
- read from
references/10665-340190.sec-025.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377:233–45.
· extracted · source:references/10665-340190.sec-025.16.jsonHakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377:233–45.
- Issued
- 2017
- Type
- article-journal
- As printed
- Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377:233–45.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.16 - provenance: extracted
- read from
references/10665-340190.sec-025.16.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.17.jsonGuidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-025.17 - provenance: extracted
- read from
references/10665-340190.sec-025.17.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update). Geneva: World Health Organization; 2017 (https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.18.jsonGuidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update). Geneva: World Health Organization; 2017 (https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update). Geneva: World Health Organization; 2017 (https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-025.18 - provenance: extracted
- read from
references/10665-340190.sec-025.18.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555–63.
· extracted · source:references/10665-340190.sec-025.19.jsonCotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555–63.
- Issued
- 2013
- Type
- article-journal
- As printed
- Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555–63.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.19 - provenance: extracted
- read from
references/10665-340190.sec-025.19.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Barlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G et al. Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation. J Int AIDS Soc. 2017;20:21552.
· extracted · source:references/10665-340190.sec-025.20.jsonBarlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G et al. Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation. J Int AIDS Soc. 2017;20:21552.
- Issued
- 2017
- Type
- article-journal
- As printed
- Barlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G et al. Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation. J Int AIDS Soc. 2017;20:21552.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.20 - provenance: extracted
- read from
references/10665-340190.sec-025.20.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Van Rie A, Sawry S, Link-Gelles R, Madhi S, Fairlie L, Verwey C et al. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016;51:157–64.
· extracted · source:references/10665-340190.sec-025.21.jsonVan Rie A, Sawry S, Link-Gelles R, Madhi S, Fairlie L, Verwey C et al. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016;51:157–64.
- Issued
- 2016
- Type
- article-journal
- As printed
- Van Rie A, Sawry S, Link-Gelles R, Madhi S, Fairlie L, Verwey C et al. Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016;51:157–64.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.21 - provenance: extracted
- read from
references/10665-340190.sec-025.21.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Cotton MF, Rabie H, Nemes E, Mujuru H, Bobat R, Njau B et al. A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries. PLoS One. 2019;14:e0211155.
· extracted · source:references/10665-340190.sec-025.22.jsonCotton MF, Rabie H, Nemes E, Mujuru H, Bobat R, Njau B et al. A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries. PLoS One. 2019;14:e0211155.
- Issued
- 2019
- Type
- article-journal
- As printed
- Cotton MF, Rabie H, Nemes E, Mujuru H, Bobat R, Njau B et al. A prospective study of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected children from high prevalence countries. PLoS One. 2019;14:e0211155.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.22 - provenance: extracted
- read from
references/10665-340190.sec-025.22.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Hannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. [Personal communication].
· extracted · source:references/10665-340190.sec-025.23.jsonHannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. [Personal communication].
- Type
- document
- As printed
- Hannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. [Personal communication].
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.23 - provenance: extracted
- read from
references/10665-340190.sec-025.23.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Kerschberger B, Jobanputra K, Schomaker M, Kabore SM, Teck R, Mabhena E et al. Feasibility of antiretroviral therapy initiation under the treat‐all policy under routine conditions: a prospective cohort study from Eswatini. J Int AIDS Soc. 2019;22:e25401.
· extracted · source:references/10665-340190.sec-025.24.jsonKerschberger B, Jobanputra K, Schomaker M, Kabore SM, Teck R, Mabhena E et al. Feasibility of antiretroviral therapy initiation under the treat‐all policy under routine conditions: a prospective cohort study from Eswatini. J Int AIDS Soc. 2019;22:e25401.
- Issued
- 2019
- Type
- article-journal
- As printed
- Kerschberger B, Jobanputra K, Schomaker M, Kabore SM, Teck R, Mabhena E et al. Feasibility of antiretroviral therapy initiation under the treat‐all policy under routine conditions: a prospective cohort study from Eswatini. J Int AIDS Soc. 2019;22:e25401.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.24 - provenance: extracted
- read from
references/10665-340190.sec-025.24.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011 (https://www.who.int/hiv/pub/hiv_disclosure/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.25.jsonGuideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011 (https://www.who.int/hiv/pub/hiv_disclosure/en, accessed 4 February 2021).
- Issued
- 2011
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: World Health Organization; 2011 (https://www.who.int/hiv/pub/hiv_disclosure/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/hiv_disclosure/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-025.25 - provenance: extracted
- read from
references/10665-340190.sec-025.25.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy-makers and managers. Geneva: World Health Organization; 2013 (https://www.who.int/hiv/pub/guidelines/adolescents/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-025.26.jsonHIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy-makers and managers. Geneva: World Health Organization; 2013 (https://www.who.int/hiv/pub/guidelines/adolescents/en, accessed 4 February 2021).
- Issued
- 2013
- Type
- document
- Accessed
- 4 February 2021
- As printed
- HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policy-makers and managers. Geneva: World Health Organization; 2013 (https://www.who.int/hiv/pub/guidelines/adolescents/en, accessed 4 February 2021).
Sources
- www.who.int/hiv/pub/guidelines/adolescents/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-025.26 - provenance: extracted
- read from
references/10665-340190.sec-025.26.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J et al. Prednisone for the prevention of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. N Engl J Med. 2018;379:1915–25.
· extracted · source:references/10665-340190.sec-025.27.jsonMeintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J et al. Prednisone for the prevention of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. N Engl J Med. 2018;379:1915–25.
- Issued
- 2018
- Type
- article-journal
- As printed
- Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J et al. Prednisone for the prevention of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. N Engl J Med. 2018;379:1915–25.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.27 - provenance: extracted
- read from
references/10665-340190.sec-025.27.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Stek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F et al. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function. Eur Respir J. 2020;55:1901692.
· extracted · source:references/10665-340190.sec-025.28.jsonStek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F et al. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function. Eur Respir J. 2020;55:1901692.
- Issued
- 2020
- Type
- article-journal
- As printed
- Stek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F et al. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function. Eur Respir J. 2020;55:1901692.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-025.28 - provenance: extracted
- read from
references/10665-340190.sec-025.28.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-025-references.md
-
Burke R, Macpherson P, Rickman H, Singh S, Hosseinipour M, Wilkinson RJ et al. What tuberculosis symptoms preclude safe same-day ART initiation? [Abstract available in Web Annex C.1]
· extracted · source:references/10665-340190.sec-028.1.jsonBurke R, Macpherson P, Rickman H, Singh S, Hosseinipour M, Wilkinson RJ et al. What tuberculosis symptoms preclude safe same-day ART initiation? [Abstract available in Web Annex C.1]
- Type
- document
- As printed
- Burke R, Macpherson P, Rickman H, Singh S, Hosseinipour M, Wilkinson RJ et al. What tuberculosis symptoms preclude safe same-day ART initiation? [Abstract available in Web Annex C.1]
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.1 - provenance: extracted
- read from
references/10665-340190.sec-028.1.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-028.2.jsonGuidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-028.2 - provenance: extracted
- read from
references/10665-340190.sec-028.2.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-028.3.jsonGlobal tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
- Issued
- 2020
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Global tuberculosis report. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/9789240013131, accessed 4 February 2021).
Sources
- www.who.int/publications/i/item/9789240013131 (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-028.3 - provenance: extracted
- read from
references/10665-340190.sec-028.3.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-028.4.jsonGuidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
- Issued
- 2017
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization; 2017 (https://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en, accessed 4 February 2021).
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-028.4 - provenance: extracted
- read from
references/10665-340190.sec-028.4.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.
· extracted · source:references/10665-340190.sec-028.5.jsonGetahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.
- Issued
- 2011
- Type
- article-journal
- As printed
- Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.5 - provenance: extracted
- read from
references/10665-340190.sec-028.5.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011 (https://www.who.int/tb/publications/ICF_IPTguidelines/en, accessed 4 February 2021).
· extracted · link · source:references/10665-340190.sec-028.6.jsonGuidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011 (https://www.who.int/tb/publications/ICF_IPTguidelines/en, accessed 4 February 2021).
- Issued
- 2011
- Type
- document
- Accessed
- 4 February 2021
- As printed
- Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011 (https://www.who.int/tb/publications/ICF_IPTguidelines/en, accessed 4 February 2021).
Sources
- www.who.int/tb/publications/ICF_IPTguidelines/en (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-028.6 - provenance: extracted
- read from
references/10665-340190.sec-028.6.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Rosen S, Maskew M, Larson BA, Brennan AT, Tsikhutsu I, Fox MP et al. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): results from an individually randomized trial in South Africa and Kenya. PLoS Med. 2019;16:e1002912.
· extracted · source:references/10665-340190.sec-028.7.jsonRosen S, Maskew M, Larson BA, Brennan AT, Tsikhutsu I, Fox MP et al. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): results from an individually randomized trial in South Africa and Kenya. PLoS Med. 2019;16:e1002912.
- Issued
- 2019
- Type
- article-journal
- As printed
- Rosen S, Maskew M, Larson BA, Brennan AT, Tsikhutsu I, Fox MP et al. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): results from an individually randomized trial in South Africa and Kenya. PLoS Med. 2019;16:e1002912.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.7 - provenance: extracted
- read from
references/10665-340190.sec-028.7.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Hamada Y, Lujan J, Schenkel K, Ford N, Getahun H. Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. The Lancet HIV. 2018;5:e515-e23. accessed 4 February 2021.
· extracted · source:references/10665-340190.sec-028.8.jsonHamada Y, Lujan J, Schenkel K, Ford N, Getahun H. Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. The Lancet HIV. 2018;5:e515-e23. accessed 4 February 2021.
- Issued
- 2018
- Type
- article-journal
- Accessed
- 4 February 2021
- As printed
- Hamada Y, Lujan J, Schenkel K, Ford N, Getahun H. Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. The Lancet HIV. 2018;5:e515-e23. accessed 4 February 2021.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.8 - provenance: extracted
- read from
references/10665-340190.sec-028.8.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Update of the WHO guidance on screening for active tuberculosis. Geneva World Health Organization; 15 June 2020 (https://www.who.int/news/item/15-06-2020-update-of-the-who-guidance-on-screening-for-active-tuberculosis).
· extracted · link · source:references/10665-340190.sec-028.9.jsonUpdate of the WHO guidance on screening for active tuberculosis. Geneva World Health Organization; 15 June 2020 (https://www.who.int/news/item/15-06-2020-update-of-the-who-guidance-on-screening-for-active-tuberculosis).
- Issued
- 2020
- Type
- document
- As printed
- Update of the WHO guidance on screening for active tuberculosis. Geneva World Health Organization; 15 June 2020 (https://www.who.int/news/item/15-06-2020-update-of-the-who-guidance-on-screening-for-active-tuberculosis).
Sources
- www.who.int/news/item/15-06-2020-update-of-the-who-guidance-on-screening-for-active-tuberculosis (canonical)
In the knowledge graph
- IRI
references/10665-340190.sec-028.9 - provenance: extracted
- read from
references/10665-340190.sec-028.9.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Maskew M, Brennan AT, Fox MP, Vezi L, Venter WD, Ehrenkranz P et al. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: the SLATE II individually randomized clinical trial. PLoS Med. 2020;17:e1003226.
· extracted · source:references/10665-340190.sec-028.10.jsonMaskew M, Brennan AT, Fox MP, Vezi L, Venter WD, Ehrenkranz P et al. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: the SLATE II individually randomized clinical trial. PLoS Med. 2020;17:e1003226.
- Issued
- 2020
- Type
- article-journal
- As printed
- Maskew M, Brennan AT, Fox MP, Vezi L, Venter WD, Ehrenkranz P et al. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: the SLATE II individually randomized clinical trial. PLoS Med. 2020;17:e1003226.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.10 - provenance: extracted
- read from
references/10665-340190.sec-028.10.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Correction: initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13:e1002050.
· extracted · source:references/10665-340190.sec-028.11.jsonRosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Correction: initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13:e1002050.
- Issued
- 2016
- Type
- article-journal
- As printed
- Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Correction: initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS Med. 2016;13:e1002050.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.11 - provenance: extracted
- read from
references/10665-340190.sec-028.11.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS medicine. 2016;13:e1002015.
· extracted · source:references/10665-340190.sec-028.12.jsonRosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS medicine. 2016;13:e1002015.
- Issued
- 2016
- Type
- article-journal
- As printed
- Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G et al. Initiating antiretroviral therapy for HIV at a patient’s first clinic visit: the RapIT randomized controlled trial. PLoS medicine. 2016;13:e1002015.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.12 - provenance: extracted
- read from
references/10665-340190.sec-028.12.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A,et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE Randomized Clinical Trial. JAMA. 2018;319:1103–12.
· extracted · source:references/10665-340190.sec-028.13.jsonLabhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A,et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE Randomized Clinical Trial. JAMA. 2018;319:1103–12.
- Issued
- 2018
- Type
- article-journal
- As printed
- Labhardt ND, Ringera I, Lejone TI, Klimkait T, Muhairwe J, Amstutz A,et al. Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults with HIV in Lesotho: the CASCADE Randomized Clinical Trial. JAMA. 2018;319:1103–12.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.13 - provenance: extracted
- read from
references/10665-340190.sec-028.13.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Scott NA, Maskew M, Fong RM, Olson IE, Brennan AT, Fox MP et al. Patients’ perceptions of quality on the process of same-day initiation of antiretroviral therapy and their early treatment experience. Patient. https://doi.org/10.1007/s40271-020-00437-4.
· extracted · doi:10.1007/s40271-020-00437-4 · source:references/10665-340190.sec-028.14.jsonScott NA, Maskew M, Fong RM, Olson IE, Brennan AT, Fox MP et al. Patients’ perceptions of quality on the process of same-day initiation of antiretroviral therapy and their early treatment experience. Patient. https://doi.org/10.1007/s40271-020-00437-4.
- Type
- document
- DOI
- 10.1007/s40271-020-00437-4
- As printed
- Scott NA, Maskew M, Fong RM, Olson IE, Brennan AT, Fox MP et al. Patients’ perceptions of quality on the process of same-day initiation of antiretroviral therapy and their early treatment experience. Patient. https://doi.org/10.1007/s40271-020-00437-4.
Sources
In the knowledge graph
- IRI
references/10665-340190.sec-028.14 - provenance: extracted
- read from
references/10665-340190.sec-028.14.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md
-
Hannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. Unpublished.
· extracted · source:references/10665-340190.sec-028.15.jsonHannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. Unpublished.
- Type
- document
- As printed
- Hannock Tweya AJ, Heller T. Initiating TB treatment and ART at the same time – observations and experiences from Martin-Preuss Center, Lilongwe, Malawi. Unpublished.
Sources
No link to the work is recorded for this reference.
In the knowledge graph
- IRI
references/10665-340190.sec-028.15 - provenance: extracted
- read from
references/10665-340190.sec-028.15.json(who-iris, sub-graph who-iris-references) - derived from
library/10665-340190/sections/sec-028-references.md